<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:63e64609-d034-4c0c-8490-3f281d38846f,g:3b404fd3-85d3-4343-9268-07f61042fc83-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.x4pharma.com/role/Cover" xlink:type="simple" xlink:href="xfor-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8dd5b4d4-aedc-4aad-8c62-f2b384884a34" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_DocumentType_8dd5b4d4-aedc-4aad-8c62-f2b384884a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_1d395fc6-41c5-4303-abf7-7ebd7c7b92a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_DocumentAnnualReport_1d395fc6-41c5-4303-abf7-7ebd7c7b92a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fae1446b-1a07-40bc-adc5-5c8b4517e168" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_DocumentPeriodEndDate_fae1446b-1a07-40bc-adc5-5c8b4517e168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_558f7035-e5e6-4d52-b013-a7c4ddc7e897" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_CurrentFiscalYearEndDate_558f7035-e5e6-4d52-b013-a7c4ddc7e897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c62b40f2-7f8f-4f64-9161-d4a836db6aaa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_DocumentTransitionReport_c62b40f2-7f8f-4f64-9161-d4a836db6aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e425a983-2d89-4bd2-8423-8eba3264447b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityFileNumber_e425a983-2d89-4bd2-8423-8eba3264447b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d8fcba0f-4296-4717-a38a-b19cf77e7291" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityRegistrantName_d8fcba0f-4296-4717-a38a-b19cf77e7291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_97cef277-5302-4a68-ba04-f0c4d798eaf5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_97cef277-5302-4a68-ba04-f0c4d798eaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a5e166eb-0824-4174-bdf7-a44f985c64fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityTaxIdentificationNumber_a5e166eb-0824-4174-bdf7-a44f985c64fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_736ab650-3df5-41e8-8384-ed1f8956ea2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityAddressAddressLine1_736ab650-3df5-41e8-8384-ed1f8956ea2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_0228725e-177a-4db9-8c57-6e8e41f8ae71" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityAddressAddressLine2_0228725e-177a-4db9-8c57-6e8e41f8ae71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ddcc06fb-7ac7-44b3-99f4-14640428e037" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityAddressCityOrTown_ddcc06fb-7ac7-44b3-99f4-14640428e037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1b8a97dc-6175-45b2-b321-a4962770c07d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityAddressStateOrProvince_1b8a97dc-6175-45b2-b321-a4962770c07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c20e74d0-7cde-4123-9c1f-ea4e0fca398a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityAddressPostalZipCode_c20e74d0-7cde-4123-9c1f-ea4e0fca398a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b0b38580-b9c1-4a6d-9e2b-6cad6c9852e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_CityAreaCode_b0b38580-b9c1-4a6d-9e2b-6cad6c9852e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1f6f4923-0dae-4359-a42e-41233db1453b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_LocalPhoneNumber_1f6f4923-0dae-4359-a42e-41233db1453b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_500fa46b-09a8-40f0-8431-a987c2b1e019" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_Security12bTitle_500fa46b-09a8-40f0-8431-a987c2b1e019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8d2eebbb-d4dd-4e58-9cc6-02d6caec13de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_TradingSymbol_8d2eebbb-d4dd-4e58-9cc6-02d6caec13de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4b472b1d-72a8-4d8d-beea-f3fef8f9d70f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_SecurityExchangeName_4b472b1d-72a8-4d8d-beea-f3fef8f9d70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_ffff5aa0-05db-4198-9085-668a96994f82" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_ffff5aa0-05db-4198-9085-668a96994f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_23080c19-6cf2-4edf-a292-042410015019" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityVoluntaryFilers_23080c19-6cf2-4edf-a292-042410015019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_d3363349-dd1a-4a41-9442-8118e9c037ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityCurrentReportingStatus_d3363349-dd1a-4a41-9442-8118e9c037ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3e382506-138c-48db-b583-ec452c5b61a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityInteractiveDataCurrent_3e382506-138c-48db-b583-ec452c5b61a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_eba73d14-30af-43dc-ab7b-6314b065a17c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_IcfrAuditorAttestationFlag_eba73d14-30af-43dc-ab7b-6314b065a17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_da05a4c0-5f2d-4cf2-bf58-fcb6dff74738" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityFilerCategory_da05a4c0-5f2d-4cf2-bf58-fcb6dff74738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a4809c66-e12b-4a26-8122-a50472457a1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntitySmallBusiness_a4809c66-e12b-4a26-8122-a50472457a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_21de7eba-506f-4847-8f0a-75fd7e79027a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityEmergingGrowthCompany_21de7eba-506f-4847-8f0a-75fd7e79027a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_27ac9fe7-993a-4b4a-951c-3d4460f4da98" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityShellCompany_27ac9fe7-993a-4b4a-951c-3d4460f4da98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_00b052ae-ebe6-49d5-b4eb-dc7638eb9cc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityPublicFloat_00b052ae-ebe6-49d5-b4eb-dc7638eb9cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_647e88ec-69ad-43e9-a8f2-89804c980659" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_647e88ec-69ad-43e9-a8f2-89804c980659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_bfa17113-0efa-4398-bc9f-c2314682819c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_bfa17113-0efa-4398-bc9f-c2314682819c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7951687e-b94d-4641-a212-7c1079f930f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_EntityCentralIndexKey_7951687e-b94d-4641-a212-7c1079f930f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d14cd7ad-72a0-45dd-be8b-6fe860338c21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_AmendmentFlag_d14cd7ad-72a0-45dd-be8b-6fe860338c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_092c9cdd-f8fa-4faf-ab26-1380dbf0dbcf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_DocumentFiscalYearFocus_092c9cdd-f8fa-4faf-ab26-1380dbf0dbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f83b3c9c-baf3-4c56-86a3-65b29946d81b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_815b97b6-e793-42a5-9613-9d7b862dabd8" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f83b3c9c-baf3-4c56-86a3-65b29946d81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/AuditInformation" xlink:type="simple" xlink:href="xfor-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AuditInformationAbstract_1c4a2e2f-12af-4808-a349-36619856bab0" xlink:href="xfor-20221231.xsd#xfor_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_c5f2e6c6-6efd-48b7-b95b-733942599119" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_AuditInformationAbstract_1c4a2e2f-12af-4808-a349-36619856bab0" xlink:to="loc_dei_AuditorName_c5f2e6c6-6efd-48b7-b95b-733942599119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_3fe9a81e-5a83-40b0-a003-1b79f09eed6a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_AuditInformationAbstract_1c4a2e2f-12af-4808-a349-36619856bab0" xlink:to="loc_dei_AuditorLocation_3fe9a81e-5a83-40b0-a003-1b79f09eed6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_a65731c6-c612-4f16-be82-69477c1e9b76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_AuditInformationAbstract_1c4a2e2f-12af-4808-a349-36619856bab0" xlink:to="loc_dei_AuditorFirmId_a65731c6-c612-4f16-be82-69477c1e9b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="xfor-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9e14cc82-c8b8-45b4-8382-f8cef30d9f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_544281a8-cf81-4970-99c7-5cdfd43029e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9e14cc82-c8b8-45b4-8382-f8cef30d9f0b" xlink:to="loc_us-gaap_AssetsAbstract_544281a8-cf81-4970-99c7-5cdfd43029e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_67a735f6-33b1-4b54-93fb-4f463af308cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_544281a8-cf81-4970-99c7-5cdfd43029e9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_67a735f6-33b1-4b54-93fb-4f463af308cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e8a28ec6-6446-407d-831a-b7257df63021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67a735f6-33b1-4b54-93fb-4f463af308cc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e8a28ec6-6446-407d-831a-b7257df63021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ResearchAndDevelopmentIncentiveReceivable_6a5f4b85-2684-4dd7-a875-6d40e41df3a3" xlink:href="xfor-20221231.xsd#xfor_ResearchAndDevelopmentIncentiveReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67a735f6-33b1-4b54-93fb-4f463af308cc" xlink:to="loc_xfor_ResearchAndDevelopmentIncentiveReceivable_6a5f4b85-2684-4dd7-a875-6d40e41df3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c523a521-98a2-42b5-aa68-e67baa92091d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67a735f6-33b1-4b54-93fb-4f463af308cc" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c523a521-98a2-42b5-aa68-e67baa92091d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3f60f419-b472-47da-acf4-a70f1eb57a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67a735f6-33b1-4b54-93fb-4f463af308cc" xlink:to="loc_us-gaap_AssetsCurrent_3f60f419-b472-47da-acf4-a70f1eb57a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d412d23c-20c4-4df4-946a-7ffa56111791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_544281a8-cf81-4970-99c7-5cdfd43029e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d412d23c-20c4-4df4-946a-7ffa56111791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e7a42a8c-32fe-48f2-a401-c0c576797482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_544281a8-cf81-4970-99c7-5cdfd43029e9" xlink:to="loc_us-gaap_Goodwill_e7a42a8c-32fe-48f2-a401-c0c576797482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ac14ef2e-b6f9-4f53-b844-5651de51885d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_544281a8-cf81-4970-99c7-5cdfd43029e9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ac14ef2e-b6f9-4f53-b844-5651de51885d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_39af319a-7a39-484d-be29-0aecead9adfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_544281a8-cf81-4970-99c7-5cdfd43029e9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_39af319a-7a39-484d-be29-0aecead9adfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c35c422f-e2aa-4a08-8391-d380972a26dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_544281a8-cf81-4970-99c7-5cdfd43029e9" xlink:to="loc_us-gaap_Assets_c35c422f-e2aa-4a08-8391-d380972a26dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9e14cc82-c8b8-45b4-8382-f8cef30d9f0b" xlink:to="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8ee1d563-4567-4a7a-819b-8ff999851199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8ee1d563-4567-4a7a-819b-8ff999851199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ee5190de-4a6d-4ec2-8101-fbda2003de5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8ee1d563-4567-4a7a-819b-8ff999851199" xlink:to="loc_us-gaap_AccountsPayableCurrent_ee5190de-4a6d-4ec2-8101-fbda2003de5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8ecafd10-5dc7-4bf7-ba36-1428d85b0249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8ee1d563-4567-4a7a-819b-8ff999851199" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8ecafd10-5dc7-4bf7-ba36-1428d85b0249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8e11df5b-a9fb-41e4-8bce-8126b7c86a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8ee1d563-4567-4a7a-819b-8ff999851199" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8e11df5b-a9fb-41e4-8bce-8126b7c86a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_50d5acff-8c2b-4e7c-86f2-1169b863bae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8ee1d563-4567-4a7a-819b-8ff999851199" xlink:to="loc_us-gaap_LongTermDebtCurrent_50d5acff-8c2b-4e7c-86f2-1169b863bae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_96b7b3a2-1a80-46e2-b64c-2571286baf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8ee1d563-4567-4a7a-819b-8ff999851199" xlink:to="loc_us-gaap_LiabilitiesCurrent_96b7b3a2-1a80-46e2-b64c-2571286baf51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LongTermDebtNonCurrentIncludingAccrection_a6727452-e373-4647-bc60-b9eb2ffeeaa6" xlink:href="xfor-20221231.xsd#xfor_LongTermDebtNonCurrentIncludingAccrection"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:to="loc_xfor_LongTermDebtNonCurrentIncludingAccrection_a6727452-e373-4647-bc60-b9eb2ffeeaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_da354bda-66c2-4c12-8ae1-3e28e4381b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_da354bda-66c2-4c12-8ae1-3e28e4381b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_5cdcde7f-4964-4362-b39e-6f9518665b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_5cdcde7f-4964-4362-b39e-6f9518665b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_633e2a0a-e509-4d32-adbd-b4ca734c9471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_633e2a0a-e509-4d32-adbd-b4ca734c9471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fac0aba0-f6d2-4620-bbae-fdd692c04bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:to="loc_us-gaap_Liabilities_fac0aba0-f6d2-4620-bbae-fdd692c04bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1c38072e-c4a8-46b7-9fe4-5fef9045aebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1fa16da5-79a2-459a-aac2-644f98d65eac" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1c38072e-c4a8-46b7-9fe4-5fef9045aebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_43daa8dc-aea0-4628-b84c-4e7e26ea81ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9e14cc82-c8b8-45b4-8382-f8cef30d9f0b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_43daa8dc-aea0-4628-b84c-4e7e26ea81ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9b86364f-7c24-4ab2-9194-3123656bed81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43daa8dc-aea0-4628-b84c-4e7e26ea81ef" xlink:to="loc_us-gaap_CommonStockValue_9b86364f-7c24-4ab2-9194-3123656bed81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c45f0876-e2f5-4153-84e9-d09a812af99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43daa8dc-aea0-4628-b84c-4e7e26ea81ef" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c45f0876-e2f5-4153-84e9-d09a812af99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_349a173d-18f8-46b5-aff7-7ef93db7788e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43daa8dc-aea0-4628-b84c-4e7e26ea81ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_349a173d-18f8-46b5-aff7-7ef93db7788e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_38f494bc-5821-4531-ab5a-999e9fe58b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43daa8dc-aea0-4628-b84c-4e7e26ea81ef" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_38f494bc-5821-4531-ab5a-999e9fe58b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a3e4773c-e537-457a-9e53-6541cad81935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43daa8dc-aea0-4628-b84c-4e7e26ea81ef" xlink:to="loc_us-gaap_StockholdersEquity_a3e4773c-e537-457a-9e53-6541cad81935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7c010445-3499-45b6-937f-2486aad00e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9e14cc82-c8b8-45b4-8382-f8cef30d9f0b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7c010445-3499-45b6-937f-2486aad00e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="xfor-20221231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7fe7bf69-a684-400d-bc1f-1626adafa1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_bbedf236-1dcf-4199-b3ef-4c6571078b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7fe7bf69-a684-400d-bc1f-1626adafa1b9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_bbedf236-1dcf-4199-b3ef-4c6571078b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5a498429-ce64-430f-a1fe-71781413a507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7fe7bf69-a684-400d-bc1f-1626adafa1b9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5a498429-ce64-430f-a1fe-71781413a507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0303aa3a-a27c-454e-b826-bcaf4f81a9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7fe7bf69-a684-400d-bc1f-1626adafa1b9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0303aa3a-a27c-454e-b826-bcaf4f81a9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_106a83f3-f5cf-4d4d-a5d9-a6cb0969facb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7fe7bf69-a684-400d-bc1f-1626adafa1b9" xlink:to="loc_us-gaap_CommonStockSharesIssued_106a83f3-f5cf-4d4d-a5d9-a6cb0969facb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="xfor-20221231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_385db778-5f8a-405b-b22a-3ed67cd30cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_385db778-5f8a-405b-b22a-3ed67cd30cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_64d895cb-960b-4a04-9bfc-7926e03737bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_OperatingExpensesAbstract_64d895cb-960b-4a04-9bfc-7926e03737bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f8d3ea3b-5822-424e-9932-d645a45fb857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_64d895cb-960b-4a04-9bfc-7926e03737bc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f8d3ea3b-5822-424e-9932-d645a45fb857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ab18f80d-c49c-400d-b4b3-340484dcc4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_64d895cb-960b-4a04-9bfc-7926e03737bc" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ab18f80d-c49c-400d-b4b3-340484dcc4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_602f7a44-7d21-43a2-b107-e1e3ca3c4620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_64d895cb-960b-4a04-9bfc-7926e03737bc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_602f7a44-7d21-43a2-b107-e1e3ca3c4620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_8bbd224a-a942-402b-9a14-8310cb559ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_64d895cb-960b-4a04-9bfc-7926e03737bc" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_8bbd224a-a942-402b-9a14-8310cb559ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_003ebcd4-d3e8-42ba-a4ca-fc301370a812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_64d895cb-960b-4a04-9bfc-7926e03737bc" xlink:to="loc_us-gaap_OperatingExpenses_003ebcd4-d3e8-42ba-a4ca-fc301370a812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e4c19e51-66e8-4077-8c59-700f56635e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_OperatingIncomeLoss_e4c19e51-66e8-4077-8c59-700f56635e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5c1cf16e-07a1-4edb-827a-9a8d1b851f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5c1cf16e-07a1-4edb-827a-9a8d1b851f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9b270ded-cab6-49c2-ba7c-a59be0ae35fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:to="loc_us-gaap_InterestExpense_9b270ded-cab6-49c2-ba7c-a59be0ae35fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_a453d3b1-73ec-43a4-a37f-a2f58025b8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_a453d3b1-73ec-43a4-a37f-a2f58025b8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cb562d3e-2d9b-47ff-8795-b5985c248f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cb562d3e-2d9b-47ff-8795-b5985c248f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_576fc854-f949-45b3-a2d0-e81001030f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_576fc854-f949-45b3-a2d0-e81001030f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_74baacbd-9cba-44c6-ad7c-527fc7c84568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_74baacbd-9cba-44c6-ad7c-527fc7c84568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18b0de9e-762e-4da6-881e-f0162ae121bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18b0de9e-762e-4da6-881e-f0162ae121bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5c56426d-1507-44d8-995c-77d355557843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ad45d95c-5881-4116-94bd-70086ad2dccf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5c56426d-1507-44d8-995c-77d355557843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b962a2eb-72c5-4bbe-bf91-e08d05e5e4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_NetIncomeLoss_b962a2eb-72c5-4bbe-bf91-e08d05e5e4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock_9d30fa6b-edfe-4a1a-80f8-0cde41976187" xlink:href="xfor-20221231.xsd#xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock_9d30fa6b-edfe-4a1a-80f8-0cde41976187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_697be74b-7e08-48cd-b0f1-10104e500edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_697be74b-7e08-48cd-b0f1-10104e500edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c1008453-8cb4-4093-9c2a-3de5af408358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_EarningsPerShareBasic_c1008453-8cb4-4093-9c2a-3de5af408358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a0df6b0b-7d5f-4a36-a14a-1480a3c7f141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a0df6b0b-7d5f-4a36-a14a-1480a3c7f141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e91bd79c-5648-43fc-9ed5-268dbc6e38a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e91bd79c-5648-43fc-9ed5-268dbc6e38a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4f8be987-e702-4bbf-bd60-fd600921668a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ad9151ae-16aa-4968-b942-04aad56f71ff" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4f8be987-e702-4bbf-bd60-fd600921668a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_613818da-fd90-4c79-b953-2ce98c2c50f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/ConsolidatedStatementsofConvertiblePreferredStockRedeemableCommonStockandStockholdersEquityDeficit" xlink:type="simple" xlink:href="xfor-20221231.xsd#ConsolidatedStatementsofConvertiblePreferredStockRedeemableCommonStockandStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/ConsolidatedStatementsofConvertiblePreferredStockRedeemableCommonStockandStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_06db1918-b88d-4e92-b5ef-06d05284064b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d25817f8-b916-488d-940e-e60abd174c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_06db1918-b88d-4e92-b5ef-06d05284064b" xlink:to="loc_us-gaap_StatementTable_d25817f8-b916-488d-940e-e60abd174c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e8d2df10-f403-44fa-b9b3-2a8a989da1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d25817f8-b916-488d-940e-e60abd174c20" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e8d2df10-f403-44fa-b9b3-2a8a989da1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b8337412-ae16-42ba-b196-24150cb32683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e8d2df10-f403-44fa-b9b3-2a8a989da1d7" xlink:to="loc_us-gaap_ClassOfStockDomain_b8337412-ae16-42ba-b196-24150cb32683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_RedeemableCommonStockMember_56635397-8059-4983-bca6-e29d593880c4" xlink:href="xfor-20221231.xsd#xfor_RedeemableCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b8337412-ae16-42ba-b196-24150cb32683" xlink:to="loc_xfor_RedeemableCommonStockMember_56635397-8059-4983-bca6-e29d593880c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c5946ba5-0f8e-4653-8f35-08335820498a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d25817f8-b916-488d-940e-e60abd174c20" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c5946ba5-0f8e-4653-8f35-08335820498a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0a91def1-9ba9-4fb4-ac7c-3c4fbfcdc19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c5946ba5-0f8e-4653-8f35-08335820498a" xlink:to="loc_us-gaap_EquityComponentDomain_0a91def1-9ba9-4fb4-ac7c-3c4fbfcdc19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_54698e39-d3c0-4425-92b2-e5ac541ca884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a91def1-9ba9-4fb4-ac7c-3c4fbfcdc19a" xlink:to="loc_us-gaap_CommonStockMember_54698e39-d3c0-4425-92b2-e5ac541ca884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_15328861-45ec-43c8-ad67-878496885e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a91def1-9ba9-4fb4-ac7c-3c4fbfcdc19a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_15328861-45ec-43c8-ad67-878496885e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d72d5f80-51be-414c-857e-ae9be82410b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a91def1-9ba9-4fb4-ac7c-3c4fbfcdc19a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d72d5f80-51be-414c-857e-ae9be82410b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_50801c06-5afb-4865-84d4-611de6b3fcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a91def1-9ba9-4fb4-ac7c-3c4fbfcdc19a" xlink:to="loc_us-gaap_RetainedEarningsMember_50801c06-5afb-4865-84d4-611de6b3fcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a7bfa502-f068-4413-acfc-6db541837ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d25817f8-b916-488d-940e-e60abd174c20" xlink:to="loc_us-gaap_StatementLineItems_a7bfa502-f068-4413-acfc-6db541837ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_fdb0bc78-3a20-491d-9db2-87061c3a1d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7bfa502-f068-4413-acfc-6db541837ff7" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_fdb0bc78-3a20-491d-9db2-87061c3a1d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_6884acb6-e0cc-4236-9090-6ee4c094eb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_fdb0bc78-3a20-491d-9db2-87061c3a1d02" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_6884acb6-e0cc-4236-9090-6ee4c094eb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1b551399-3b9e-4cc4-af9a-45a43c8843fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_fdb0bc78-3a20-491d-9db2-87061c3a1d02" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1b551399-3b9e-4cc4-af9a-45a43c8843fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_85bcd8d0-f243-4ae6-b0fe-17397a3e7d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_fdb0bc78-3a20-491d-9db2-87061c3a1d02" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_85bcd8d0-f243-4ae6-b0fe-17397a3e7d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0364bf11-39cc-4f3a-8b55-114daf211674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_fdb0bc78-3a20-491d-9db2-87061c3a1d02" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0364bf11-39cc-4f3a-8b55-114daf211674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7bfa502-f068-4413-acfc-6db541837ff7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_53f80ea7-ec2c-41a1-b966-f75ce93fe128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_SharesOutstanding_53f80ea7-ec2c-41a1-b966-f75ce93fe128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_57ff56fa-edf4-4b61-9cba-7a59d1c7b941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockholdersEquity_57ff56fa-edf4-4b61-9cba-7a59d1c7b941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a4d7cd22-f6fb-4b55-8924-a7623978c647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a4d7cd22-f6fb-4b55-8924-a7623978c647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6ff7e7bc-be98-41a8-b3e1-68d18c07f4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6ff7e7bc-be98-41a8-b3e1-68d18c07f4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8f0d428a-68c0-4afa-aee6-d36976605d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8f0d428a-68c0-4afa-aee6-d36976605d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c054df6-f860-499f-a163-1abec8593c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c054df6-f860-499f-a163-1abec8593c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_64995f80-4cbe-4145-b4c9-8aa3f5db4b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_64995f80-4cbe-4145-b4c9-8aa3f5db4b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c127c2ce-7aec-46b8-9449-897698108afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c127c2ce-7aec-46b8-9449-897698108afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_141ec8a2-bbc4-40ac-b258-784fd1ca5465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_141ec8a2-bbc4-40ac-b258-784fd1ca5465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ab5800bf-8790-4796-a87a-9802ff30763a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ab5800bf-8790-4796-a87a-9802ff30763a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_e7427c03-d575-470d-b81b-d2f8b41ef38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_e7427c03-d575-470d-b81b-d2f8b41ef38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_1a22054a-a803-4d3e-ba53-fc82ba075331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_1a22054a-a803-4d3e-ba53-fc82ba075331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_34017ddd-fae7-4e91-a605-d7db5f3c2cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_34017ddd-fae7-4e91-a605-d7db5f3c2cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6a52cacc-5f62-4d4a-a448-fb7b6d909db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_NetIncomeLoss_6a52cacc-5f62-4d4a-a448-fb7b6d909db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_StockIssuedDuringPeriodSharesWarrantsExercised_5dea1017-b0ef-4a32-9448-27dcd1cbe69c" xlink:href="xfor-20221231.xsd#xfor_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_xfor_StockIssuedDuringPeriodSharesWarrantsExercised_5dea1017-b0ef-4a32-9448-27dcd1cbe69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_StockIssuedDuringPeriodValueWarrantsExercised_ea92c109-b5f5-45b0-8707-4a5881a22675" xlink:href="xfor-20221231.xsd#xfor_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_xfor_StockIssuedDuringPeriodValueWarrantsExercised_ea92c109-b5f5-45b0-8707-4a5881a22675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_c03d8728-d17d-4c88-a37b-bacbc77d973f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_c03d8728-d17d-4c88-a37b-bacbc77d973f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e9d6db37-27d8-4df4-9506-7e93b191d1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_SharesOutstanding_e9d6db37-27d8-4df4-9506-7e93b191d1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3bc1f022-a6b6-4c53-970d-c6726ceb7992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_60730b66-fb66-4303-a5d5-87e2d1d9399c" xlink:to="loc_us-gaap_StockholdersEquity_3bc1f022-a6b6-4c53-970d-c6726ceb7992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="xfor-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dce3d4da-256b-4d9d-8313-8ff0740ec215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dce3d4da-256b-4d9d-8313-8ff0740ec215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_65974057-dac2-424c-81f4-0f5e1b90dc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dce3d4da-256b-4d9d-8313-8ff0740ec215" xlink:to="loc_us-gaap_ProfitLoss_65974057-dac2-424c-81f4-0f5e1b90dc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dce3d4da-256b-4d9d-8313-8ff0740ec215" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_198e6f31-0fcc-414b-83ca-cfd1bf420b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_us-gaap_ShareBasedCompensation_198e6f31-0fcc-414b-83ca-cfd1bf420b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_73194e57-be6c-4379-a0ee-b28e6a8091a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_73194e57-be6c-4379-a0ee-b28e6a8091a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9870a9e0-03e0-43a8-84e8-4f6c8dc32bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9870a9e0-03e0-43a8-84e8-4f6c8dc32bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_NonCashLeaseExpense_8d78e488-bdf0-46bf-b440-fdcf76586e5b" xlink:href="xfor-20221231.xsd#xfor_NonCashLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_xfor_NonCashLeaseExpense_8d78e488-bdf0-46bf-b440-fdcf76586e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_NonCashInterestExpense_3382bb01-c273-46b3-b53d-2c5f301a1dd3" xlink:href="xfor-20221231.xsd#xfor_NonCashInterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_xfor_NonCashInterestExpense_3382bb01-c273-46b3-b53d-2c5f301a1dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_59d63702-add3-43c2-8b56-41490a32d2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_59d63702-add3-43c2-8b56-41490a32d2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ChangeInFairValueOfConvertiblePreferredStockWarrantLiability_b0bff190-0a06-4278-b5a9-1a140d257f62" xlink:href="xfor-20221231.xsd#xfor_ChangeInFairValueOfConvertiblePreferredStockWarrantLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_xfor_ChangeInFairValueOfConvertiblePreferredStockWarrantLiability_b0bff190-0a06-4278-b5a9-1a140d257f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_bb0f39bf-e26a-42e4-9f18-eb99986ee4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_bb0f39bf-e26a-42e4-9f18-eb99986ee4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3a8e9511-8931-4154-b5e0-7ebcbbd7ef62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7ca259-fda0-412a-ab30-29f859d5c2bd" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3a8e9511-8931-4154-b5e0-7ebcbbd7ef62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0255c2f6-ea23-4b75-8c62-58196ae69962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3a8e9511-8931-4154-b5e0-7ebcbbd7ef62" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0255c2f6-ea23-4b75-8c62-58196ae69962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_edc1b6f3-ba32-4a7b-80a3-4fbce6c8f3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3a8e9511-8931-4154-b5e0-7ebcbbd7ef62" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_edc1b6f3-ba32-4a7b-80a3-4fbce6c8f3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a76b4223-1cdb-4b5d-96ff-77f842ff90a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3a8e9511-8931-4154-b5e0-7ebcbbd7ef62" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a76b4223-1cdb-4b5d-96ff-77f842ff90a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IncreaseDecreaseInLeaseLiabilities_ee0d1120-102b-4ca2-95ef-25c5221d1f85" xlink:href="xfor-20221231.xsd#xfor_IncreaseDecreaseInLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3a8e9511-8931-4154-b5e0-7ebcbbd7ef62" xlink:to="loc_xfor_IncreaseDecreaseInLeaseLiabilities_ee0d1120-102b-4ca2-95ef-25c5221d1f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IncreaseDecreaseInOperatingLeaseRightOfUseAssetNonCashPotion_0c70a2fb-c633-42a0-b13c-811442c4fad5" xlink:href="xfor-20221231.xsd#xfor_IncreaseDecreaseInOperatingLeaseRightOfUseAssetNonCashPotion"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3a8e9511-8931-4154-b5e0-7ebcbbd7ef62" xlink:to="loc_xfor_IncreaseDecreaseInOperatingLeaseRightOfUseAssetNonCashPotion_0c70a2fb-c633-42a0-b13c-811442c4fad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64140297-1e03-4dac-b85e-04ea3c6a4fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dce3d4da-256b-4d9d-8313-8ff0740ec215" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64140297-1e03-4dac-b85e-04ea3c6a4fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ca87e4f2-de99-424b-baa9-7f8a288fed63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ca87e4f2-de99-424b-baa9-7f8a288fed63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_c8666ae4-3f00-4a62-b42f-695c214646a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ca87e4f2-de99-424b-baa9-7f8a288fed63" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_c8666ae4-3f00-4a62-b42f-695c214646a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ab245cd-ac31-4e6b-aba1-48ccbce69698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ca87e4f2-de99-424b-baa9-7f8a288fed63" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ab245cd-ac31-4e6b-aba1-48ccbce69698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ProceedsFromExerciseOfStockOptionsAndWarrants_b68547ea-6a1d-4f51-bb18-fcec43df5a44" xlink:href="xfor-20221231.xsd#xfor_ProceedsFromExerciseOfStockOptionsAndWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:to="loc_xfor_ProceedsFromExerciseOfStockOptionsAndWarrants_b68547ea-6a1d-4f51-bb18-fcec43df5a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceCostsRelatedToSaleOfWarrantsAndFeesPaidForAmendmentsToLoanAndSecurityAgreement_2538f57d-eb02-43ad-8cbe-1998abbdd667" xlink:href="xfor-20221231.xsd#xfor_IssuanceCostsRelatedToSaleOfWarrantsAndFeesPaidForAmendmentsToLoanAndSecurityAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:to="loc_xfor_IssuanceCostsRelatedToSaleOfWarrantsAndFeesPaidForAmendmentsToLoanAndSecurityAgreement_2538f57d-eb02-43ad-8cbe-1998abbdd667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_76f3c08d-cff7-4ddf-990b-6c7801f89aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_76f3c08d-cff7-4ddf-990b-6c7801f89aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_0edc6a67-f866-4835-bcf7-11db7e33de2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_0edc6a67-f866-4835-bcf7-11db7e33de2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a9e6eef5-161f-40ee-b900-d06576a493ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a9e6eef5-161f-40ee-b900-d06576a493ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts_be4648ed-ea12-4fdf-aacc-8af0f3178040" xlink:href="xfor-20221231.xsd#xfor_ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:to="loc_xfor_ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts_be4648ed-ea12-4fdf-aacc-8af0f3178040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5246a7e0-7dcd-4cd6-acad-219378cf6ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5246a7e0-7dcd-4cd6-acad-219378cf6ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2365eb08-9716-4bdb-b2f6-564070b7888d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_766d982e-d195-48b8-9f73-70d9542cbac8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2365eb08-9716-4bdb-b2f6-564070b7888d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9c4f6ef3-3920-444a-aa24-2e5a77a1d47f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9c4f6ef3-3920-444a-aa24-2e5a77a1d47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ae9f1e54-6bba-46a6-a1aa-2a1893d149fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ae9f1e54-6bba-46a6-a1aa-2a1893d149fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7494f335-3e48-415f-8a26-8a718f83c128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7494f335-3e48-415f-8a26-8a718f83c128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b80a31b0-52f1-4107-8499-ca07c04db1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b80a31b0-52f1-4107-8499-ca07c04db1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4e5c32cf-bd64-4cc4-8e40-c23be9878449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4e5c32cf-bd64-4cc4-8e40-c23be9878449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_63fcf92d-fe9a-429a-8cae-be3d01e52cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4e5c32cf-bd64-4cc4-8e40-c23be9878449" xlink:to="loc_us-gaap_InterestPaidNet_63fcf92d-fe9a-429a-8cae-be3d01e52cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c5e66148-8341-4687-82ff-3028726cde4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5cacd22d-16f5-41e1-9494-9d85be9093e5" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c5e66148-8341-4687-82ff-3028726cde4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CapitalExpendituresAndIntangibleAssetsIncurredButNotYetPaid_a410e509-58ce-41e0-a923-9a9fe056d7b3" xlink:href="xfor-20221231.xsd#xfor_CapitalExpendituresAndIntangibleAssetsIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c5e66148-8341-4687-82ff-3028726cde4b" xlink:to="loc_xfor_CapitalExpendituresAndIntangibleAssetsIncurredButNotYetPaid_a410e509-58ce-41e0-a923-9a9fe056d7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred_64dbf063-f25e-41fa-b98e-b5c69d47c936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLeaseObligationsIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c5e66148-8341-4687-82ff-3028726cde4b" xlink:to="loc_us-gaap_CapitalLeaseObligationsIncurred_64dbf063-f25e-41fa-b98e-b5c69d47c936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_StockAndWarrantIssuanceCostsIncurredButNotYetPaid_b2eaf199-5b50-494b-bafc-2f0f8e94a866" xlink:href="xfor-20221231.xsd#xfor_StockAndWarrantIssuanceCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c5e66148-8341-4687-82ff-3028726cde4b" xlink:to="loc_xfor_StockAndWarrantIssuanceCostsIncurredButNotYetPaid_b2eaf199-5b50-494b-bafc-2f0f8e94a866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NatureoftheBusinessandBasisofPresentation" xlink:type="simple" xlink:href="xfor-20221231.xsd#NatureoftheBusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NatureoftheBusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_516461aa-b1fd-41ee-90d9-1331fbe4b010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_08971fd2-16fc-4874-ac25-a2282c263f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_516461aa-b1fd-41ee-90d9-1331fbe4b010" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_08971fd2-16fc-4874-ac25-a2282c263f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="xfor-20221231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_665af1a1-7142-45c8-ad6c-8ebea0483735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_aecdcc20-26c1-40a8-ad21-7a6ae6e982ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_665af1a1-7142-45c8-ad6c-8ebea0483735" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_aecdcc20-26c1-40a8-ad21-7a6ae6e982ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreements" xlink:type="simple" xlink:href="xfor-20221231.xsd#LicenseCollaborationandFundingAgreements"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_42ef54ee-f7fa-410b-8f23-9d54ab434205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_8ea95763-c063-46e5-b3cd-c201e9b6aaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_42ef54ee-f7fa-410b-8f23-9d54ab434205" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_8ea95763-c063-46e5-b3cd-c201e9b6aaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilities" xlink:type="simple" xlink:href="xfor-20221231.xsd#FairValueofFinancialAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f123d3a0-7cd9-4c9c-ba06-f9457442e977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_c72f1420-6729-4177-88c3-11344b90a155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f123d3a0-7cd9-4c9c-ba06-f9457442e977" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_c72f1420-6729-4177-88c3-11344b90a155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="xfor-20221231.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_36b08b12-e5b4-4401-bc5a-6f60b12de5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0a1d6603-9e52-4675-bf08-46b296b13b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_36b08b12-e5b4-4401-bc5a-6f60b12de5d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0a1d6603-9e52-4675-bf08-46b296b13b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/AccruedExpenses" xlink:type="simple" xlink:href="xfor-20221231.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_577f210c-9ce6-40ac-b8b7-a3ac495ec54c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AccruedExpensesTextBlock_a49cdbc8-6339-478e-a225-00af7ca948b0" xlink:href="xfor-20221231.xsd#xfor_AccruedExpensesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_577f210c-9ce6-40ac-b8b7-a3ac495ec54c" xlink:to="loc_xfor_AccruedExpensesTextBlock_a49cdbc8-6339-478e-a225-00af7ca948b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebt" xlink:type="simple" xlink:href="xfor-20221231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a32d5254-9eb2-48f3-a2e1-53c6f635d28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_b1929aad-a6f8-41cb-84d2-d0fc98ba9fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a32d5254-9eb2-48f3-a2e1-53c6f635d28f" xlink:to="loc_us-gaap_LongTermDebtTextBlock_b1929aad-a6f8-41cb-84d2-d0fc98ba9fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/Leases" xlink:type="simple" xlink:href="xfor-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e08acefd-7c3f-45cf-8d6c-2b6ea9df68c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8292b1da-22fe-4884-8b13-2d890770844d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e08acefd-7c3f-45cf-8d6c-2b6ea9df68c5" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8292b1da-22fe-4884-8b13-2d890770844d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="xfor-20221231.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1c0d8f95-4a52-4382-a987-cf3c03150ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d9377fa1-7464-4fc0-bf96-48470ccd392a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1c0d8f95-4a52-4382-a987-cf3c03150ca0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d9377fa1-7464-4fc0-bf96-48470ccd392a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PreferredandCommonStockWarrants" xlink:type="simple" xlink:href="xfor-20221231.xsd#PreferredandCommonStockWarrants"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PreferredandCommonStockWarrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_627e2ffb-6154-478d-a228-d3437085d667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0b71dfdd-291a-4525-b3f7-42289e941608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_627e2ffb-6154-478d-a228-d3437085d667" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0b71dfdd-291a-4525-b3f7-42289e941608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommonStockRedeemableCommonStockandConvertiblePreferredStockconvertedtoCommonStock" xlink:type="simple" xlink:href="xfor-20221231.xsd#CommonStockRedeemableCommonStockandConvertiblePreferredStockconvertedtoCommonStock"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommonStockRedeemableCommonStockandConvertiblePreferredStockconvertedtoCommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e6602711-35ea-48cc-b756-fe00af6f6fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_62621560-32c1-435b-b5b2-2efc0519c3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e6602711-35ea-48cc-b756-fe00af6f6fb0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_62621560-32c1-435b-b5b2-2efc0519c3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="xfor-20221231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2c2d0aac-0065-4fd3-add0-dca6a846c6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_670bf3a4-53be-4a0b-91fd-d5f8b8374a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2c2d0aac-0065-4fd3-add0-dca6a846c6d3" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_670bf3a4-53be-4a0b-91fd-d5f8b8374a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="xfor-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3f9596b6-72d5-4fbb-b5b7-baed078ed794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_267a5c79-3fdb-47a2-b01b-6b71c9b73d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f9596b6-72d5-4fbb-b5b7-baed078ed794" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_267a5c79-3fdb-47a2-b01b-6b71c9b73d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShare" xlink:type="simple" xlink:href="xfor-20221231.xsd#NetLossperShare"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_79bef50b-a5f6-4333-9a07-d20f579bee63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_56ef9545-5fbf-460d-ba3b-fab997772ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_79bef50b-a5f6-4333-9a07-d20f579bee63" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_56ef9545-5fbf-460d-ba3b-fab997772ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LossonTransferofNonfinancialAssets" xlink:type="simple" xlink:href="xfor-20221231.xsd#LossonTransferofNonfinancialAssets"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LossonTransferofNonfinancialAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8f7c2db-4384-4bbf-8ac9-550ba90dc5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_cda6c20b-94af-4da0-980a-90d1e815a007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8f7c2db-4384-4bbf-8ac9-550ba90dc5c7" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_cda6c20b-94af-4da0-980a-90d1e815a007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SubsequentEvents" xlink:type="simple" xlink:href="xfor-20221231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_cdca8924-9f16-4c00-9e48-3105ddb2945e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_3ca21ffd-50a6-434a-be35-dd960be2c983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_cdca8924-9f16-4c00-9e48-3105ddb2945e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_3ca21ffd-50a6-434a-be35-dd960be2c983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="xfor-20221231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_0d7d5c7c-06b8-467a-9e16-752686fc9180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_UseOfEstimates_0d7d5c7c-06b8-467a-9e16-752686fc9180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2eac5b22-4cef-4156-84dc-c7b4f4c6a217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2eac5b22-4cef-4156-84dc-c7b4f4c6a217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_1618c530-2986-40d5-ae9b-f85a4cdd06d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_1618c530-2986-40d5-ae9b-f85a4cdd06d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_613ec28c-d3aa-4970-abac-5834dbaf0d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_613ec28c-d3aa-4970-abac-5834dbaf0d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_e225c063-4182-44b9-adbb-81580e5dcab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_e225c063-4182-44b9-adbb-81580e5dcab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_RightOfUseAssetAndLeaseLiabilityPolicyPolicyTextBlock_973ddce4-93ef-45fc-9fde-7ff155b48ff6" xlink:href="xfor-20221231.xsd#xfor_RightOfUseAssetAndLeaseLiabilityPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_xfor_RightOfUseAssetAndLeaseLiabilityPolicyPolicyTextBlock_973ddce4-93ef-45fc-9fde-7ff155b48ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_28754b67-6c0d-490a-bb67-49c8a88c4985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_28754b67-6c0d-490a-bb67-49c8a88c4985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_e5e8332d-6167-4089-bf3d-0ba04e2544eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_e5e8332d-6167-4089-bf3d-0ba04e2544eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_ddfac74d-dba2-4aae-8aca-c2459f7178b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_ddfac74d-dba2-4aae-8aca-c2459f7178b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_3e3d9da6-2a78-43ae-9161-255cce0b339f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_3e3d9da6-2a78-43ae-9161-255cce0b339f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c026e31b-e20b-46c3-b62b-12f9f49960e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c026e31b-e20b-46c3-b62b-12f9f49960e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ResearchAndDevelopmentProgramsPolicyPolicyTextBlock_872bf3e7-64bc-47cd-a712-f30d915b7f4e" xlink:href="xfor-20221231.xsd#xfor_ResearchAndDevelopmentProgramsPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_xfor_ResearchAndDevelopmentProgramsPolicyPolicyTextBlock_872bf3e7-64bc-47cd-a712-f30d915b7f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_38461d51-505b-45d5-8d18-a9dbe8ae62dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_38461d51-505b-45d5-8d18-a9dbe8ae62dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicyCostsIncurredToRenewOrExtend_74d44a44-8f5f-4399-b0ea-2ff403b7e861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicyCostsIncurredToRenewOrExtend"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicyCostsIncurredToRenewOrExtend_74d44a44-8f5f-4399-b0ea-2ff403b7e861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_ad41c513-7545-42cf-bb53-ccdc069383f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_DebtPolicyTextBlock_ad41c513-7545-42cf-bb53-ccdc069383f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_81d975d1-1731-493c-9f65-ec10f3ad9b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_81d975d1-1731-493c-9f65-ec10f3ad9b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_ab1323cc-d523-4282-82bf-26c813267bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_ab1323cc-d523-4282-82bf-26c813267bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_f1a860eb-099c-4f1f-9f92-c64b9ba6eb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_f1a860eb-099c-4f1f-9f92-c64b9ba6eb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_32331283-4fd4-425e-9824-37d5781bee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_32331283-4fd4-425e-9824-37d5781bee4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_eef2fb69-afd1-4cd5-9b91-be7843b99c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_eef2fb69-afd1-4cd5-9b91-be7843b99c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ebfc06d0-a78d-4dfe-8749-443a1c4ef051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24598936-1aa5-4240-b308-627c6c4d6f3e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ebfc06d0-a78d-4dfe-8749-443a1c4ef051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cdb2d0b8-eeac-4f35-a3fe-bdafacb4bbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensatingBalancesTextBlock_5f1fb950-c589-4a6c-b6fb-be42023ed31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensatingBalancesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cdb2d0b8-eeac-4f35-a3fe-bdafacb4bbf8" xlink:to="loc_us-gaap_ScheduleOfCompensatingBalancesTextBlock_5f1fb950-c589-4a6c-b6fb-be42023ed31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashToCashFlowsTableTextBlock_72a9e323-5f32-46a3-8073-67b839dba8a4" xlink:href="xfor-20221231.xsd#xfor_ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashToCashFlowsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cdb2d0b8-eeac-4f35-a3fe-bdafacb4bbf8" xlink:to="loc_xfor_ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashToCashFlowsTableTextBlock_72a9e323-5f32-46a3-8073-67b839dba8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_70e6bb25-c11b-48d2-9cb0-f7a812a43a68" xlink:href="xfor-20221231.xsd#xfor_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cdb2d0b8-eeac-4f35-a3fe-bdafacb4bbf8" xlink:to="loc_xfor_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_70e6bb25-c11b-48d2-9cb0-f7a812a43a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#FairValueofFinancialAssetsandLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dcdd647f-0881-43bc-a4e5-1f20a81bc5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_2d097f32-6bbc-43f4-80d4-211188ec034d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcdd647f-0881-43bc-a4e5-1f20a81bc5eb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_2d097f32-6bbc-43f4-80d4-211188ec034d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4320d93f-ba6f-4006-869c-0c516bf495c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcdd647f-0881-43bc-a4e5-1f20a81bc5eb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4320d93f-ba6f-4006-869c-0c516bf495c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_dc2c26ad-8842-4bb4-940c-aafd1e2d53fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcdd647f-0881-43bc-a4e5-1f20a81bc5eb" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_dc2c26ad-8842-4bb4-940c-aafd1e2d53fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_c736e9da-31d6-4c82-aab0-61b1c7b1bc05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcdd647f-0881-43bc-a4e5-1f20a81bc5eb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_c736e9da-31d6-4c82-aab0-61b1c7b1bc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_09950496-d89c-4b63-9c1b-33806fe3c8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a096dbbd-a50a-4f09-90e6-299da2810043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_09950496-d89c-4b63-9c1b-33806fe3c8db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a096dbbd-a50a-4f09-90e6-299da2810043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_d2c67a66-0fa3-4797-b0ae-bf15c9c60c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_8dfa50b5-f8ee-4572-90f5-2cca710dfbed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d2c67a66-0fa3-4797-b0ae-bf15c9c60c73" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_8dfa50b5-f8ee-4572-90f5-2cca710dfbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bf70ea32-996a-4d90-8fd0-902c7c9a87bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_594b0884-bbb8-42eb-99b5-886ac6f72c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf70ea32-996a-4d90-8fd0-902c7c9a87bd" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_594b0884-bbb8-42eb-99b5-886ac6f72c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_71998c4d-74ab-49fb-b255-4096fba4b4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf70ea32-996a-4d90-8fd0-902c7c9a87bd" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_71998c4d-74ab-49fb-b255-4096fba4b4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_3577daad-6716-4d68-a626-79e58e8079ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf70ea32-996a-4d90-8fd0-902c7c9a87bd" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_3577daad-6716-4d68-a626-79e58e8079ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ea25a04c-8b1b-4da3-a693-f405f399cb90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_15817aca-238c-4e03-83a0-8d7dbc54c9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ea25a04c-8b1b-4da3-a693-f405f399cb90" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_15817aca-238c-4e03-83a0-8d7dbc54c9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9bb28688-7eba-4a2b-bf94-758759388043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ea25a04c-8b1b-4da3-a693-f405f399cb90" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9bb28688-7eba-4a2b-bf94-758759388043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PreferredandCommonStockWarrantsTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#PreferredandCommonStockWarrantsTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PreferredandCommonStockWarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9c77543e-787b-4b97-9ab9-b4a1e3e01493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ScheduleOfOutstandingWarrantsTableTableTextBlock_8e77491e-685d-4bfe-8716-8a92e2d0e84b" xlink:href="xfor-20221231.xsd#xfor_ScheduleOfOutstandingWarrantsTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9c77543e-787b-4b97-9ab9-b4a1e3e01493" xlink:to="loc_xfor_ScheduleOfOutstandingWarrantsTableTableTextBlock_8e77491e-685d-4bfe-8716-8a92e2d0e84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_e891d445-8adc-4d1c-be8d-7fd534a281e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9c77543e-787b-4b97-9ab9-b4a1e3e01493" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_e891d445-8adc-4d1c-be8d-7fd534a281e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d81724fd-261a-4484-a009-021352e9bb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_33072978-bf95-4709-a476-f9db4231b57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d81724fd-261a-4484-a009-021352e9bb7d" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_33072978-bf95-4709-a476-f9db4231b57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b8b647b2-2b14-4bfa-a2a9-2c66ef945489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d81724fd-261a-4484-a009-021352e9bb7d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b8b647b2-2b14-4bfa-a2a9-2c66ef945489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_0eb7b76c-fdad-4d1c-bff6-b282f7798825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d81724fd-261a-4484-a009-021352e9bb7d" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_0eb7b76c-fdad-4d1c-bff6-b282f7798825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_6e337771-8546-4323-89ab-d5536abb0d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d81724fd-261a-4484-a009-021352e9bb7d" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_6e337771-8546-4323-89ab-d5536abb0d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6c660b74-1bee-4ab0-a298-149e5e6875b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_0059e169-c190-4190-ad6d-ad3ccd65e9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c660b74-1bee-4ab0-a298-149e5e6875b2" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_0059e169-c190-4190-ad6d-ad3ccd65e9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_20c5a3b6-0c0d-4db8-a81b-59d571e97174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c660b74-1bee-4ab0-a298-149e5e6875b2" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_20c5a3b6-0c0d-4db8-a81b-59d571e97174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1921e902-3852-44ea-bf9a-9a26ea500539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c660b74-1bee-4ab0-a298-149e5e6875b2" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1921e902-3852-44ea-bf9a-9a26ea500539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_503f02db-43fd-481a-9315-062d83e50b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c660b74-1bee-4ab0-a298-149e5e6875b2" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_503f02db-43fd-481a-9315-062d83e50b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_fcb30281-f41a-436c-9a55-9ca31f18f4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c660b74-1bee-4ab0-a298-149e5e6875b2" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_fcb30281-f41a-436c-9a55-9ca31f18f4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="xfor-20221231.xsd#NetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3c735e9f-8c38-4e73-9228-4f17dd1a3299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_13852c84-279f-4dc5-ae41-a04c98659443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c735e9f-8c38-4e73-9228-4f17dd1a3299" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_13852c84-279f-4dc5-ae41-a04c98659443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ca967359-08bb-4dcd-bc23-9ab9de03bb70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c735e9f-8c38-4e73-9228-4f17dd1a3299" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ca967359-08bb-4dcd-bc23-9ab9de03bb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NatureoftheBusinessandBasisofPresentationDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#NatureoftheBusinessandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NatureoftheBusinessandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a6ae3ac5-25c3-49e4-9281-2209f418ae75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0550299-8ee1-4beb-96f2-950c8008afca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a6ae3ac5-25c3-49e4-9281-2209f418ae75" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0550299-8ee1-4beb-96f2-950c8008afca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f3ffee00-76a3-40d0-9d73-fb4031115c42" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0550299-8ee1-4beb-96f2-950c8008afca" xlink:to="loc_srt_StatementScenarioAxis_f3ffee00-76a3-40d0-9d73-fb4031115c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3312fe53-07c9-4ccc-a18e-2d54eed04d25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f3ffee00-76a3-40d0-9d73-fb4031115c42" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3312fe53-07c9-4ccc-a18e-2d54eed04d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_9cca8b66-3bd3-4df2-abe1-f28f399e0a5a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_3312fe53-07c9-4ccc-a18e-2d54eed04d25" xlink:to="loc_srt_ScenarioForecastMember_9cca8b66-3bd3-4df2-abe1-f28f399e0a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5bd8d8f6-3753-4e30-ab66-1559371ec22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0550299-8ee1-4beb-96f2-950c8008afca" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_5bd8d8f6-3753-4e30-ab66-1559371ec22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7eea6631-99d7-4712-96d9-a35d7d6b4ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5bd8d8f6-3753-4e30-ab66-1559371ec22f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7eea6631-99d7-4712-96d9-a35d7d6b4ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_69e38d5b-0685-42c8-948d-b46dc3d7c19d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5bd8d8f6-3753-4e30-ab66-1559371ec22f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_69e38d5b-0685-42c8-948d-b46dc3d7c19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4b147848-6622-4068-a99a-f30aa5e2a109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5bd8d8f6-3753-4e30-ab66-1559371ec22f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4b147848-6622-4068-a99a-f30aa5e2a109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_68e080f6-f155-4b6d-92b9-031a599d9717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5bd8d8f6-3753-4e30-ab66-1559371ec22f" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_68e080f6-f155-4b6d-92b9-031a599d9717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ProceedsFromIssuanceOfCommonStockBeforeUnderwritingDiscountsCommissionsAndOtherExpenses_4636a8fc-eedd-4954-b6fe-38aa5bd5f6c6" xlink:href="xfor-20221231.xsd#xfor_ProceedsFromIssuanceOfCommonStockBeforeUnderwritingDiscountsCommissionsAndOtherExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5bd8d8f6-3753-4e30-ab66-1559371ec22f" xlink:to="loc_xfor_ProceedsFromIssuanceOfCommonStockBeforeUnderwritingDiscountsCommissionsAndOtherExpenses_4636a8fc-eedd-4954-b6fe-38aa5bd5f6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequired_a1af5539-a4b2-4fc9-9562-be1d6ea0d837" xlink:href="xfor-20221231.xsd#xfor_DebtInstrumentDebtCovenantMinimumCashRequired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5bd8d8f6-3753-4e30-ab66-1559371ec22f" xlink:to="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequired_a1af5539-a4b2-4fc9-9562-be1d6ea0d837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofRestrictedCashDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#SummaryofSignificantAccountingPoliciesScheduleofRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cfc955bd-bdbd-4a92-abdc-3bd6196508f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_d9b6f1e2-c508-4c89-885a-006d39c9e3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfc955bd-bdbd-4a92-abdc-3bd6196508f8" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_d9b6f1e2-c508-4c89-885a-006d39c9e3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e6bb26fb-dc46-478e-b48e-8cccf9cf5cf0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_d9b6f1e2-c508-4c89-885a-006d39c9e3cb" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e6bb26fb-dc46-478e-b48e-8cccf9cf5cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_0c30830c-3eb7-4c72-948f-9c33391a4837" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e6bb26fb-dc46-478e-b48e-8cccf9cf5cf0" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_0c30830c-3eb7-4c72-948f-9c33391a4837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_WalthamLeaseMember_0f78ab3c-5f6c-4c6d-b4e5-625767013864" xlink:href="xfor-20221231.xsd#xfor_WalthamLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_0c30830c-3eb7-4c72-948f-9c33391a4837" xlink:to="loc_xfor_WalthamLeaseMember_0f78ab3c-5f6c-4c6d-b4e5-625767013864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ViennaLeaseArrangementMember_1a9ea198-214d-4cd2-8a2b-cbb740c5b4ec" xlink:href="xfor-20221231.xsd#xfor_ViennaLeaseArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_0c30830c-3eb7-4c72-948f-9c33391a4837" xlink:to="loc_xfor_ViennaLeaseArrangementMember_1a9ea198-214d-4cd2-8a2b-cbb740c5b4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AllstonLeaseMember_1eabfc65-3d80-454d-a640-59f5b59f471f" xlink:href="xfor-20221231.xsd#xfor_AllstonLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_0c30830c-3eb7-4c72-948f-9c33391a4837" xlink:to="loc_xfor_AllstonLeaseMember_1eabfc65-3d80-454d-a640-59f5b59f471f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_eb2c2099-53a7-4f85-b1f3-1e9fe9485d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_d9b6f1e2-c508-4c89-885a-006d39c9e3cb" xlink:to="loc_us-gaap_CreditFacilityAxis_eb2c2099-53a7-4f85-b1f3-1e9fe9485d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a9320285-7596-4da7-8555-5f3dec3ee436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_eb2c2099-53a7-4f85-b1f3-1e9fe9485d4a" xlink:to="loc_us-gaap_CreditFacilityDomain_a9320285-7596-4da7-8555-5f3dec3ee436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a16b948a-3efa-4d55-876a-6f44517fbfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a9320285-7596-4da7-8555-5f3dec3ee436" xlink:to="loc_us-gaap_LetterOfCreditMember_a16b948a-3efa-4d55-876a-6f44517fbfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_34af1e2b-39a5-44ec-b425-f5e36e767925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_d9b6f1e2-c508-4c89-885a-006d39c9e3cb" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_34af1e2b-39a5-44ec-b425-f5e36e767925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_be703f47-fee8-49a7-b72c-24b15efe6f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_34af1e2b-39a5-44ec-b425-f5e36e767925" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_be703f47-fee8-49a7-b72c-24b15efe6f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_4ece62a0-28b2-4349-8377-8ce711cfe50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_34af1e2b-39a5-44ec-b425-f5e36e767925" xlink:to="loc_us-gaap_RestrictedCash_4ece62a0-28b2-4349-8377-8ce711cfe50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_93e27883-e31a-4ae2-8368-f2cee6e0b4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_34af1e2b-39a5-44ec-b425-f5e36e767925" xlink:to="loc_us-gaap_RestrictedCashCurrent_93e27883-e31a-4ae2-8368-f2cee6e0b4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList_0c170618-d51e-4fc9-badb-11625435f851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_34af1e2b-39a5-44ec-b425-f5e36e767925" xlink:to="loc_us-gaap_RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList_0c170618-d51e-4fc9-badb-11625435f851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_afe63d43-4d9a-4b04-b817-a57eaa491d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f40dc905-69b4-4ddd-9c66-02fcedf76e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_afe63d43-4d9a-4b04-b817-a57eaa491d1e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f40dc905-69b4-4ddd-9c66-02fcedf76e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_9c7ab67a-1b1c-46f9-9537-91158947f39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_afe63d43-4d9a-4b04-b817-a57eaa491d1e" xlink:to="loc_us-gaap_RestrictedCashCurrent_9c7ab67a-1b1c-46f9-9537-91158947f39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_2de094db-9785-4d34-8c0c-180259a68137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_afe63d43-4d9a-4b04-b817-a57eaa491d1e" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_2de094db-9785-4d34-8c0c-180259a68137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_641e9327-3bba-4971-916f-abca70b3585e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_afe63d43-4d9a-4b04-b817-a57eaa491d1e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_641e9327-3bba-4971-916f-abca70b3585e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b668d941-f223-4ec4-9cd8-2b5428107682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eddae93c-7f02-45ba-ab18-e23898752f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b668d941-f223-4ec4-9cd8-2b5428107682" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eddae93c-7f02-45ba-ab18-e23898752f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30b25bc9-0f27-4c9f-a722-cdc9e1efed89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eddae93c-7f02-45ba-ab18-e23898752f8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30b25bc9-0f27-4c9f-a722-cdc9e1efed89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f276f512-06ab-415e-a3e3-df779e11064a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30b25bc9-0f27-4c9f-a722-cdc9e1efed89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f276f512-06ab-415e-a3e3-df779e11064a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_79513fb1-b16e-419a-ab61-0f8e02d8e9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f276f512-06ab-415e-a3e3-df779e11064a" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_79513fb1-b16e-419a-ab61-0f8e02d8e9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_10060832-d4ac-4e22-9582-e193bb5e3e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f276f512-06ab-415e-a3e3-df779e11064a" xlink:to="loc_us-gaap_ComputerEquipmentMember_10060832-d4ac-4e22-9582-e193bb5e3e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_c4b65eb8-d911-4d00-9e94-2bd6ac7ae82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f276f512-06ab-415e-a3e3-df779e11064a" xlink:to="loc_us-gaap_EquipmentMember_c4b65eb8-d911-4d00-9e94-2bd6ac7ae82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_83d3f071-5990-4795-9510-9b987f956ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f276f512-06ab-415e-a3e3-df779e11064a" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_83d3f071-5990-4795-9510-9b987f956ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2d56af7d-5310-4406-8c23-7e2a6e21cc0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eddae93c-7f02-45ba-ab18-e23898752f8a" xlink:to="loc_srt_RangeAxis_2d56af7d-5310-4406-8c23-7e2a6e21cc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae935581-ff5b-4cc5-a752-ac26db85a44f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2d56af7d-5310-4406-8c23-7e2a6e21cc0c" xlink:to="loc_srt_RangeMember_ae935581-ff5b-4cc5-a752-ac26db85a44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4461d13a-78f1-4f07-8c25-115dbd8518f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae935581-ff5b-4cc5-a752-ac26db85a44f" xlink:to="loc_srt_MinimumMember_4461d13a-78f1-4f07-8c25-115dbd8518f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_efd8ebe2-da42-45ad-ada8-644338c63185" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae935581-ff5b-4cc5-a752-ac26db85a44f" xlink:to="loc_srt_MaximumMember_efd8ebe2-da42-45ad-ada8-644338c63185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_45a0d8e6-f3a7-41ba-a6ef-d5af0b070253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eddae93c-7f02-45ba-ab18-e23898752f8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_45a0d8e6-f3a7-41ba-a6ef-d5af0b070253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e245c386-a9b3-4495-aa87-d2db03b303f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_45a0d8e6-f3a7-41ba-a6ef-d5af0b070253" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e245c386-a9b3-4495-aa87-d2db03b303f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_07f9ccd8-1b1c-424b-9bf8-b428d360dc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_45a0d8e6-f3a7-41ba-a6ef-d5af0b070253" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_07f9ccd8-1b1c-424b-9bf8-b428d360dc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#SummaryofSignificantPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_dbb843dd-90a4-4668-b6e1-421463db95fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33f52417-6809-4bb1-90ba-4c226b7e287e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dbb843dd-90a4-4668-b6e1-421463db95fe" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33f52417-6809-4bb1-90ba-4c226b7e287e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4e7ba97e-5a4c-4dce-a63f-7dc0a6c8a750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33f52417-6809-4bb1-90ba-4c226b7e287e" xlink:to="loc_us-gaap_DebtInstrumentAxis_4e7ba97e-5a4c-4dce-a63f-7dc0a6c8a750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d8249649-4ba6-4651-87dc-fbee417d207f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4e7ba97e-5a4c-4dce-a63f-7dc0a6c8a750" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d8249649-4ba6-4651-87dc-fbee417d207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesFirstAmendedLoanAgreementMember_0495b167-1269-4778-bc9d-7e9e9643b23c" xlink:href="xfor-20221231.xsd#xfor_HerculesFirstAmendedLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8249649-4ba6-4651-87dc-fbee417d207f" xlink:to="loc_xfor_HerculesFirstAmendedLoanAgreementMember_0495b167-1269-4778-bc9d-7e9e9643b23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2e27502a-19dc-4bc6-9714-3dc5bf57d9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33f52417-6809-4bb1-90ba-4c226b7e287e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2e27502a-19dc-4bc6-9714-3dc5bf57d9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_076a1e42-c637-47df-bc35-118873864b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2e27502a-19dc-4bc6-9714-3dc5bf57d9ca" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_076a1e42-c637-47df-bc35-118873864b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_080e5404-5b18-4ce9-8a69-18d8d67f1493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2e27502a-19dc-4bc6-9714-3dc5bf57d9ca" xlink:to="loc_us-gaap_NumberOfReportingUnits_080e5404-5b18-4ce9-8a69-18d8d67f1493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4f27e472-5a7a-4b36-8266-181794983734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2e27502a-19dc-4bc6-9714-3dc5bf57d9ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4f27e472-5a7a-4b36-8266-181794983734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequired_c114d03b-519f-4670-a1a9-916203ef0dd4" xlink:href="xfor-20221231.xsd#xfor_DebtInstrumentDebtCovenantMinimumCashRequired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2e27502a-19dc-4bc6-9714-3dc5bf57d9ca" xlink:to="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequired_c114d03b-519f-4670-a1a9-916203ef0dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsGenzymeAgreementDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LicenseCollaborationandFundingAgreementsGenzymeAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsGenzymeAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76a23da3-0bc2-4a3b-a0dc-cdff538703b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_08beb4c2-d22f-4572-bb35-0461ff8acd49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76a23da3-0bc2-4a3b-a0dc-cdff538703b4" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_08beb4c2-d22f-4572-bb35-0461ff8acd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_67eaf8f4-d3eb-42b8-801c-ed202b4e6363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_08beb4c2-d22f-4572-bb35-0461ff8acd49" xlink:to="loc_us-gaap_TypeOfArrangementAxis_67eaf8f4-d3eb-42b8-801c-ed202b4e6363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a146251a-8c38-4ddc-a8e4-8bc6f3b51551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_67eaf8f4-d3eb-42b8-801c-ed202b4e6363" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a146251a-8c38-4ddc-a8e4-8bc6f3b51551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_GenzymeAgreementMember_820ccc25-502a-40aa-b6df-06cbd7c73f94" xlink:href="xfor-20221231.xsd#xfor_GenzymeAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a146251a-8c38-4ddc-a8e4-8bc6f3b51551" xlink:to="loc_xfor_GenzymeAgreementMember_820ccc25-502a-40aa-b6df-06cbd7c73f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_62292eb9-d60a-497a-a856-1ad0c73f006f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_08beb4c2-d22f-4572-bb35-0461ff8acd49" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_62292eb9-d60a-497a-a856-1ad0c73f006f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MilestonePayments_01ed3338-9015-4364-a195-4cdcce86b1b5" xlink:href="xfor-20221231.xsd#xfor_MilestonePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_62292eb9-d60a-497a-a856-1ad0c73f006f" xlink:to="loc_xfor_MilestonePayments_01ed3338-9015-4364-a195-4cdcce86b1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PaymentOnObligationUnderLicenseAgreement_228ebb70-dc14-482e-a5ac-206d17589263" xlink:href="xfor-20221231.xsd#xfor_PaymentOnObligationUnderLicenseAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_62292eb9-d60a-497a-a856-1ad0c73f006f" xlink:to="loc_xfor_PaymentOnObligationUnderLicenseAgreement_228ebb70-dc14-482e-a5ac-206d17589263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsGeorgetownAgreementDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LicenseCollaborationandFundingAgreementsGeorgetownAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsGeorgetownAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b9297b99-e538-4f1e-8b7e-3c2a5b64b938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8540420a-3528-4da5-8a12-c736775346f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b9297b99-e538-4f1e-8b7e-3c2a5b64b938" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8540420a-3528-4da5-8a12-c736775346f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_70139c80-1cd5-4cd7-bd5c-644761f54975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8540420a-3528-4da5-8a12-c736775346f8" xlink:to="loc_us-gaap_TypeOfArrangementAxis_70139c80-1cd5-4cd7-bd5c-644761f54975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2ba6bc3e-0fe1-40d5-90b3-256477b96f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_70139c80-1cd5-4cd7-bd5c-644761f54975" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2ba6bc3e-0fe1-40d5-90b3-256477b96f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_GeorgetownMember_1f251c71-ed42-4279-baaa-adaacfc0cbd9" xlink:href="xfor-20221231.xsd#xfor_GeorgetownMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2ba6bc3e-0fe1-40d5-90b3-256477b96f76" xlink:to="loc_xfor_GeorgetownMember_1f251c71-ed42-4279-baaa-adaacfc0cbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e6a2cb9b-ba0c-4b24-a0e1-b485c602df77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8540420a-3528-4da5-8a12-c736775346f8" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e6a2cb9b-ba0c-4b24-a0e1-b485c602df77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_OneTimeUpfrontPayment_8a3a1529-0370-4578-a941-5c78a12c5aaf" xlink:href="xfor-20221231.xsd#xfor_OneTimeUpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e6a2cb9b-ba0c-4b24-a0e1-b485c602df77" xlink:to="loc_xfor_OneTimeUpfrontPayment_8a3a1529-0370-4578-a941-5c78a12c5aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MilestonePaymentsPaid_4ad850e9-4066-4661-b3aa-ca120b757552" xlink:href="xfor-20221231.xsd#xfor_MilestonePaymentsPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e6a2cb9b-ba0c-4b24-a0e1-b485c602df77" xlink:to="loc_xfor_MilestonePaymentsPaid_4ad850e9-4066-4661-b3aa-ca120b757552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MilestoneContractTerminationPeriod_ea952621-07b0-4c3d-8256-8b303d1cc29b" xlink:href="xfor-20221231.xsd#xfor_MilestoneContractTerminationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e6a2cb9b-ba0c-4b24-a0e1-b485c602df77" xlink:to="loc_xfor_MilestoneContractTerminationPeriod_ea952621-07b0-4c3d-8256-8b303d1cc29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PaymentOnObligationUnderLicenseAgreement_63537ffa-5e5b-45e0-9d24-cd7f21158fe8" xlink:href="xfor-20221231.xsd#xfor_PaymentOnObligationUnderLicenseAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e6a2cb9b-ba0c-4b24-a0e1-b485c602df77" xlink:to="loc_xfor_PaymentOnObligationUnderLicenseAgreement_63537ffa-5e5b-45e0-9d24-cd7f21158fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MilestonePaymentObligation_dfc12197-4b8a-428c-bba9-abedc5bda25c" xlink:href="xfor-20221231.xsd#xfor_MilestonePaymentObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e6a2cb9b-ba0c-4b24-a0e1-b485c602df77" xlink:to="loc_xfor_MilestonePaymentObligation_dfc12197-4b8a-428c-bba9-abedc5bda25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsBethIsraelDeaconessMedicalCenterAgreementsDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LicenseCollaborationandFundingAgreementsBethIsraelDeaconessMedicalCenterAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsBethIsraelDeaconessMedicalCenterAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1d3874e4-7f60-4779-b2a1-5ecabd2d06c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f24970b6-671e-4482-8055-ccced610b5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1d3874e4-7f60-4779-b2a1-5ecabd2d06c6" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f24970b6-671e-4482-8055-ccced610b5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7224d1ef-5f3a-4946-b3fd-4102b7786b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f24970b6-671e-4482-8055-ccced610b5cb" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7224d1ef-5f3a-4946-b3fd-4102b7786b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_087fed8e-44b9-4c1e-b5fa-9f8c7f4e48f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7224d1ef-5f3a-4946-b3fd-4102b7786b43" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_087fed8e-44b9-4c1e-b5fa-9f8c7f4e48f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_BidmcAgreementMember_5fea19b6-b032-4a09-b1d6-4e60cd8c23c1" xlink:href="xfor-20221231.xsd#xfor_BidmcAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_087fed8e-44b9-4c1e-b5fa-9f8c7f4e48f4" xlink:to="loc_xfor_BidmcAgreementMember_5fea19b6-b032-4a09-b1d6-4e60cd8c23c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DFCIMember_72b4078e-1282-4fe3-9dad-135c1cfd4524" xlink:href="xfor-20221231.xsd#xfor_DFCIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_087fed8e-44b9-4c1e-b5fa-9f8c7f4e48f4" xlink:to="loc_xfor_DFCIMember_72b4078e-1282-4fe3-9dad-135c1cfd4524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f24970b6-671e-4482-8055-ccced610b5cb" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_OneTimeUpfrontPayment_78ce9554-bd1f-4d77-9fcd-056030684cca" xlink:href="xfor-20221231.xsd#xfor_OneTimeUpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:to="loc_xfor_OneTimeUpfrontPayment_78ce9554-bd1f-4d77-9fcd-056030684cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PaymentOnObligationUnderLicenseAgreement_91763301-158f-45a1-9a3f-6139042e2182" xlink:href="xfor-20221231.xsd#xfor_PaymentOnObligationUnderLicenseAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:to="loc_xfor_PaymentOnObligationUnderLicenseAgreement_91763301-158f-45a1-9a3f-6139042e2182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CollaborativeAgreementExpenseReimbursement_bebb8840-f034-4d7c-b0fe-5f4631084fe4" xlink:href="xfor-20221231.xsd#xfor_CollaborativeAgreementExpenseReimbursement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:to="loc_xfor_CollaborativeAgreementExpenseReimbursement_bebb8840-f034-4d7c-b0fe-5f4631084fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CollaborativeArrangementObligationPercentage_e10dc42f-ca74-43ad-8b5f-449978148194" xlink:href="xfor-20221231.xsd#xfor_CollaborativeArrangementObligationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:to="loc_xfor_CollaborativeArrangementObligationPercentage_e10dc42f-ca74-43ad-8b5f-449978148194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CollaborativeAgreementFutureExpectedAnnualFeesYearOneThroughThree_b052f20e-0bd5-48a5-82bc-7f2e03f0ef6a" xlink:href="xfor-20221231.xsd#xfor_CollaborativeAgreementFutureExpectedAnnualFeesYearOneThroughThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:to="loc_xfor_CollaborativeAgreementFutureExpectedAnnualFeesYearOneThroughThree_b052f20e-0bd5-48a5-82bc-7f2e03f0ef6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CollaborativeAgreementFutureExpectedAnnualFeesYearFourThroughSix_5e5dd79e-d619-4ced-bdd4-f27d50c6e897" xlink:href="xfor-20221231.xsd#xfor_CollaborativeAgreementFutureExpectedAnnualFeesYearFourThroughSix"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:to="loc_xfor_CollaborativeAgreementFutureExpectedAnnualFeesYearFourThroughSix_5e5dd79e-d619-4ced-bdd4-f27d50c6e897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CollaborativeAgreementFutureExpectedAnnualFeesThereafter_e8f0c5d4-dce9-4085-a7cb-70f5d4903c0a" xlink:href="xfor-20221231.xsd#xfor_CollaborativeAgreementFutureExpectedAnnualFeesThereafter"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_963a8c75-031d-4c8a-962e-c7287940fcae" xlink:to="loc_xfor_CollaborativeAgreementFutureExpectedAnnualFeesThereafter_e8f0c5d4-dce9-4085-a7cb-70f5d4903c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsResearchandDevelopmentIncentiveProgramDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LicenseCollaborationandFundingAgreementsResearchandDevelopmentIncentiveProgramDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsResearchandDevelopmentIncentiveProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eda6311a-6a2c-461b-bf8c-c60683b11faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_6da51253-2690-46c7-9cb6-1fd6df583faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eda6311a-6a2c-461b-bf8c-c60683b11faf" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_6da51253-2690-46c7-9cb6-1fd6df583faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9ae21920-5ea9-41b4-9d5e-320a476304b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_6da51253-2690-46c7-9cb6-1fd6df583faf" xlink:to="loc_srt_StatementGeographicalAxis_9ae21920-5ea9-41b4-9d5e-320a476304b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aafb4776-fcc6-4c7f-88d9-cab597b985b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9ae21920-5ea9-41b4-9d5e-320a476304b2" xlink:to="loc_srt_SegmentGeographicalDomain_aafb4776-fcc6-4c7f-88d9-cab597b985b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MTSAustriaMember_44065fd5-8b6e-44f4-918e-c9138fad0ece" xlink:href="xfor-20221231.xsd#xfor_MTSAustriaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aafb4776-fcc6-4c7f-88d9-cab597b985b1" xlink:to="loc_xfor_MTSAustriaMember_44065fd5-8b6e-44f4-918e-c9138fad0ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_b2146d22-d47d-403f-b783-bfee87233fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_6da51253-2690-46c7-9cb6-1fd6df583faf" xlink:to="loc_us-gaap_TypeOfArrangementAxis_b2146d22-d47d-403f-b783-bfee87233fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8b62bd9a-8748-4e32-bd11-30f781be2288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b2146d22-d47d-403f-b783-bfee87233fa8" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8b62bd9a-8748-4e32-bd11-30f781be2288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ResearchAndDevelopmentIncentiveProgramMember_96f03de9-c474-4984-ae21-4f5d1c887bf9" xlink:href="xfor-20221231.xsd#xfor_ResearchAndDevelopmentIncentiveProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8b62bd9a-8748-4e32-bd11-30f781be2288" xlink:to="loc_xfor_ResearchAndDevelopmentIncentiveProgramMember_96f03de9-c474-4984-ae21-4f5d1c887bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AbbiskoAgreementMember_06c32448-fb0e-4c72-822c-7c7aa40d3422" xlink:href="xfor-20221231.xsd#xfor_AbbiskoAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8b62bd9a-8748-4e32-bd11-30f781be2288" xlink:to="loc_xfor_AbbiskoAgreementMember_06c32448-fb0e-4c72-822c-7c7aa40d3422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fad24d22-844e-47f0-9e37-d30706cac952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_6da51253-2690-46c7-9cb6-1fd6df583faf" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fad24d22-844e-47f0-9e37-d30706cac952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ReimbursementRateForResearchAndDevelopment_b14d9fc3-df3e-49d2-b1f7-751d16407bab" xlink:href="xfor-20221231.xsd#xfor_ReimbursementRateForResearchAndDevelopment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fad24d22-844e-47f0-9e37-d30706cac952" xlink:to="loc_xfor_ReimbursementRateForResearchAndDevelopment_b14d9fc3-df3e-49d2-b1f7-751d16407bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_GrantAndIncentiveReceivables_8595ba72-5632-4eef-a4ee-5cbe9350cc85" xlink:href="xfor-20221231.xsd#xfor_GrantAndIncentiveReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fad24d22-844e-47f0-9e37-d30706cac952" xlink:to="loc_xfor_GrantAndIncentiveReceivables_8595ba72-5632-4eef-a4ee-5cbe9350cc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_00f29814-3d39-4abd-90d6-255a47c9bd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fad24d22-844e-47f0-9e37-d30706cac952" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_00f29814-3d39-4abd-90d6-255a47c9bd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PotentialMilestonePaymentsReceivable_4c5a291e-ffff-43e6-919e-c07723ac46ba" xlink:href="xfor-20221231.xsd#xfor_PotentialMilestonePaymentsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fad24d22-844e-47f0-9e37-d30706cac952" xlink:to="loc_xfor_PotentialMilestonePaymentsReceivable_4c5a291e-ffff-43e6-919e-c07723ac46ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LicenseCollaborationandFundingAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bb808428-880d-480e-bfda-efecb9fe1749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_596c0a63-3018-4b9f-b614-89470b4817c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bb808428-880d-480e-bfda-efecb9fe1749" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_596c0a63-3018-4b9f-b614-89470b4817c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_d180c773-8a94-49ab-8597-44adb82346f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_596c0a63-3018-4b9f-b614-89470b4817c3" xlink:to="loc_us-gaap_TypeOfArrangementAxis_d180c773-8a94-49ab-8597-44adb82346f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_739cbec3-7650-49aa-80bf-c51d32c21b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_d180c773-8a94-49ab-8597-44adb82346f4" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_739cbec3-7650-49aa-80bf-c51d32c21b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AbbiskoAgreementMember_e6be1fc1-2bb8-488e-af11-b1ddb995eef2" xlink:href="xfor-20221231.xsd#xfor_AbbiskoAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_739cbec3-7650-49aa-80bf-c51d32c21b91" xlink:to="loc_xfor_AbbiskoAgreementMember_e6be1fc1-2bb8-488e-af11-b1ddb995eef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_2dc2f1b9-851b-4e86-a5a5-b9a32ab9427b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_596c0a63-3018-4b9f-b614-89470b4817c3" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_2dc2f1b9-851b-4e86-a5a5-b9a32ab9427b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PotentialMilestonePaymentsReceivable_759d83e7-5f58-4d2b-be5f-442644cc592d" xlink:href="xfor-20221231.xsd#xfor_PotentialMilestonePaymentsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_2dc2f1b9-851b-4e86-a5a5-b9a32ab9427b" xlink:to="loc_xfor_PotentialMilestonePaymentsReceivable_759d83e7-5f58-4d2b-be5f-442644cc592d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_92fa3d86-9d67-47ac-884d-22e2ebaf80d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_2dc2f1b9-851b-4e86-a5a5-b9a32ab9427b" xlink:to="loc_us-gaap_Revenues_92fa3d86-9d67-47ac-884d-22e2ebaf80d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#FairValueofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5ae4480e-c423-4109-89b4-857d5212ebd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3ac43011-145c-43a7-bde8-d6abd7bf4d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5ae4480e-c423-4109-89b4-857d5212ebd7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3ac43011-145c-43a7-bde8-d6abd7bf4d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8493fdbd-e060-4d43-bd21-9e5ad835d608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3ac43011-145c-43a7-bde8-d6abd7bf4d78" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8493fdbd-e060-4d43-bd21-9e5ad835d608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_24ced423-babb-4d75-92b1-8c90aa639e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8493fdbd-e060-4d43-bd21-9e5ad835d608" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_24ced423-babb-4d75-92b1-8c90aa639e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_386997c1-3a57-42e1-9fcf-35718f728f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_24ced423-babb-4d75-92b1-8c90aa639e21" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_386997c1-3a57-42e1-9fcf-35718f728f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8744f7ca-a729-42cb-9ce3-d1dc46759d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_24ced423-babb-4d75-92b1-8c90aa639e21" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8744f7ca-a729-42cb-9ce3-d1dc46759d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_71e8d21c-f363-4630-b17f-92adc99bbb96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_24ced423-babb-4d75-92b1-8c90aa639e21" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_71e8d21c-f363-4630-b17f-92adc99bbb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_39922108-d129-455d-b303-103bd44400b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3ac43011-145c-43a7-bde8-d6abd7bf4d78" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_39922108-d129-455d-b303-103bd44400b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bbb99e9-c3ba-4da1-9a57-6fff3aefd1de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_39922108-d129-455d-b303-103bd44400b5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bbb99e9-c3ba-4da1-9a57-6fff3aefd1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4891c94c-2cec-41ef-b5fb-464ddc7d6aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bbb99e9-c3ba-4da1-9a57-6fff3aefd1de" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4891c94c-2cec-41ef-b5fb-464ddc7d6aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8afb0e5c-3d18-49d0-a8f0-2eccac823442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3ac43011-145c-43a7-bde8-d6abd7bf4d78" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8afb0e5c-3d18-49d0-a8f0-2eccac823442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dfb2c9af-98ee-4687-9715-ccd18777ff2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8afb0e5c-3d18-49d0-a8f0-2eccac823442" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dfb2c9af-98ee-4687-9715-ccd18777ff2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_d4cbbdc9-7fed-4081-b669-30de0465cc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dfb2c9af-98ee-4687-9715-ccd18777ff2e" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_d4cbbdc9-7fed-4081-b669-30de0465cc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_1cd2daf2-bab5-4835-8377-0116f38a8435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dfb2c9af-98ee-4687-9715-ccd18777ff2e" xlink:to="loc_us-gaap_WarrantMember_1cd2daf2-bab5-4835-8377-0116f38a8435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ab104e2d-b959-46c7-b5c3-2010be73da08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3ac43011-145c-43a7-bde8-d6abd7bf4d78" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ab104e2d-b959-46c7-b5c3-2010be73da08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_83e9746b-66ad-47da-a6c7-bb310f00062e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ab104e2d-b959-46c7-b5c3-2010be73da08" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_83e9746b-66ad-47da-a6c7-bb310f00062e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b3567cd2-5c50-4ad5-9e4b-06a4b8d37c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ab104e2d-b959-46c7-b5c3-2010be73da08" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b3567cd2-5c50-4ad5-9e4b-06a4b8d37c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_99718f47-37d5-473d-a7d3-d078b8bcba42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ab104e2d-b959-46c7-b5c3-2010be73da08" xlink:to="loc_us-gaap_DerivativeLiabilities_99718f47-37d5-473d-a7d3-d078b8bcba42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_3041e084-071b-4c81-a69f-97608597e107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ab104e2d-b959-46c7-b5c3-2010be73da08" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_3041e084-071b-4c81-a69f-97608597e107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#FairValueofFinancialAssetsandLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c65b2371-7b36-4ef2-891c-225dcc4bd068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_945712f5-607a-4609-87fe-4fc0b6376cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c65b2371-7b36-4ef2-891c-225dcc4bd068" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_945712f5-607a-4609-87fe-4fc0b6376cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7f4a636c-5335-4270-bb36-4e834cde27ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_945712f5-607a-4609-87fe-4fc0b6376cf8" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7f4a636c-5335-4270-bb36-4e834cde27ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_85b2cfee-3bd0-4302-9cc9-04cb2166d25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7f4a636c-5335-4270-bb36-4e834cde27ee" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_85b2cfee-3bd0-4302-9cc9-04cb2166d25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_GenzymeAgreementMember_da7c77e4-c948-41d3-8378-07f5f6f2697e" xlink:href="xfor-20221231.xsd#xfor_GenzymeAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_85b2cfee-3bd0-4302-9cc9-04cb2166d25c" xlink:to="loc_xfor_GenzymeAgreementMember_da7c77e4-c948-41d3-8378-07f5f6f2697e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_26a258e0-c17f-459c-98e6-3efeb6582a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_945712f5-607a-4609-87fe-4fc0b6376cf8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_26a258e0-c17f-459c-98e6-3efeb6582a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ebd61d04-535a-48c4-a6b5-7f36da63c3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_26a258e0-c17f-459c-98e6-3efeb6582a4f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ebd61d04-535a-48c4-a6b5-7f36da63c3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d0f1ab1f-52d3-469d-850d-dc2471589e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ebd61d04-535a-48c4-a6b5-7f36da63c3a4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d0f1ab1f-52d3-469d-850d-dc2471589e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ac5152e8-f2a1-4670-893c-9f25076f3888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_945712f5-607a-4609-87fe-4fc0b6376cf8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ac5152e8-f2a1-4670-893c-9f25076f3888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_becd986e-d159-43c2-92c3-207ec8be8eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ac5152e8-f2a1-4670-893c-9f25076f3888" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_becd986e-d159-43c2-92c3-207ec8be8eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e9683484-c663-4f17-8ed8-8a9ec41d7c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_becd986e-d159-43c2-92c3-207ec8be8eb6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e9683484-c663-4f17-8ed8-8a9ec41d7c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_183f35f1-7101-4e3b-8e19-a768e1943c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_945712f5-607a-4609-87fe-4fc0b6376cf8" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_183f35f1-7101-4e3b-8e19-a768e1943c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ec997d5e-4bf3-47d9-b98c-522c753ee288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_183f35f1-7101-4e3b-8e19-a768e1943c20" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ec997d5e-4bf3-47d9-b98c-522c753ee288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_a63dac71-52f6-4ede-ad66-570ce7a59e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ec997d5e-4bf3-47d9-b98c-522c753ee288" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_a63dac71-52f6-4ede-ad66-570ce7a59e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3f7372f0-01aa-4c5b-a47d-ff9a4ba095d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_945712f5-607a-4609-87fe-4fc0b6376cf8" xlink:to="loc_us-gaap_DebtInstrumentAxis_3f7372f0-01aa-4c5b-a47d-ff9a4ba095d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1146786d-22a4-46d2-89d8-1654527c46b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3f7372f0-01aa-4c5b-a47d-ff9a4ba095d9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1146786d-22a4-46d2-89d8-1654527c46b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesAmendedAndRestatedLoanAgreementMember_44bcaddf-3536-45c8-80f5-6637b970ec1a" xlink:href="xfor-20221231.xsd#xfor_HerculesAmendedAndRestatedLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1146786d-22a4-46d2-89d8-1654527c46b5" xlink:to="loc_xfor_HerculesAmendedAndRestatedLoanAgreementMember_44bcaddf-3536-45c8-80f5-6637b970ec1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_303ec660-3e85-431c-8396-b449e6d06dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_945712f5-607a-4609-87fe-4fc0b6376cf8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_303ec660-3e85-431c-8396-b449e6d06dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d699c275-3602-4270-9605-9fd9c7cef13e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_303ec660-3e85-431c-8396-b449e6d06dca" xlink:to="loc_us-gaap_DerivativeLiabilities_d699c275-3602-4270-9605-9fd9c7cef13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ad5aceb7-6ef2-4a0a-b79e-6e9d47529ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_303ec660-3e85-431c-8396-b449e6d06dca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ad5aceb7-6ef2-4a0a-b79e-6e9d47529ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_79e7f300-703c-4700-ac28-39a5754f4be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_303ec660-3e85-431c-8396-b449e6d06dca" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_79e7f300-703c-4700-ac28-39a5754f4be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesAggregateFairValueofWarrantandDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#FairValueofFinancialAssetsandLiabilitiesAggregateFairValueofWarrantandDerivativeLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesAggregateFairValueofWarrantandDerivativeLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_980d4463-6c94-451c-b4b8-1b371de1f385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_ee032197-0a54-4d51-a3b0-6ed9d4a96a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_980d4463-6c94-451c-b4b8-1b371de1f385" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_ee032197-0a54-4d51-a3b0-6ed9d4a96a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a0b3c55-89ca-4524-a2c4-0414c62cb5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_ee032197-0a54-4d51-a3b0-6ed9d4a96a6d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a0b3c55-89ca-4524-a2c4-0414c62cb5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45b99ace-4a37-4330-840b-1cfd226ad498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a0b3c55-89ca-4524-a2c4-0414c62cb5f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45b99ace-4a37-4330-840b-1cfd226ad498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_389037be-6734-4423-9176-00d83994bb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45b99ace-4a37-4330-840b-1cfd226ad498" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_389037be-6734-4423-9176-00d83994bb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ec70e0a4-0450-4b77-a152-acfee40d1f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_ee032197-0a54-4d51-a3b0-6ed9d4a96a6d" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ec70e0a4-0450-4b77-a152-acfee40d1f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_31d87f25-93af-4cb6-9de7-564249245c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ec70e0a4-0450-4b77-a152-acfee40d1f7b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_31d87f25-93af-4cb6-9de7-564249245c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8979afc8-51d9-417e-9c99-63a9093588c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_31d87f25-93af-4cb6-9de7-564249245c59" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8979afc8-51d9-417e-9c99-63a9093588c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_d7cf6e57-202f-4940-a661-6d98206311be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_31d87f25-93af-4cb6-9de7-564249245c59" xlink:to="loc_us-gaap_WarrantMember_d7cf6e57-202f-4940-a661-6d98206311be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_2d2e8f04-d823-48d9-aeaf-3484faef252a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_ee032197-0a54-4d51-a3b0-6ed9d4a96a6d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_2d2e8f04-d823-48d9-aeaf-3484faef252a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_de2ee253-8602-4d79-b28c-1f3a6ca27cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_2d2e8f04-d823-48d9-aeaf-3484faef252a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_de2ee253-8602-4d79-b28c-1f3a6ca27cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PIPEWarrantsMember_dabd416f-2fd2-4a1f-a0d2-7eb4e2778f0d" xlink:href="xfor-20221231.xsd#xfor_PIPEWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_de2ee253-8602-4d79-b28c-1f3a6ca27cd0" xlink:to="loc_xfor_PIPEWarrantsMember_dabd416f-2fd2-4a1f-a0d2-7eb4e2778f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassCWarrantsMember_da78b2f4-a142-4768-9cea-6a70eaddbd63" xlink:href="xfor-20221231.xsd#xfor_ClassCWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_de2ee253-8602-4d79-b28c-1f3a6ca27cd0" xlink:to="loc_xfor_ClassCWarrantsMember_da78b2f4-a142-4768-9cea-6a70eaddbd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_e9ca135e-5864-48f7-a0d8-3c089870086d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_ee032197-0a54-4d51-a3b0-6ed9d4a96a6d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_e9ca135e-5864-48f7-a0d8-3c089870086d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5f0b7ccf-b1b0-40ce-abce-22917a3a65a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_e9ca135e-5864-48f7-a0d8-3c089870086d" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5f0b7ccf-b1b0-40ce-abce-22917a3a65a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_32203c37-6d43-4a42-91b0-149f62747be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5f0b7ccf-b1b0-40ce-abce-22917a3a65a1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_32203c37-6d43-4a42-91b0-149f62747be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1b01cfd0-10a2-4f19-aef2-91260bf0ec4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5f0b7ccf-b1b0-40ce-abce-22917a3a65a1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1b01cfd0-10a2-4f19-aef2-91260bf0ec4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_7cc6908b-9482-4166-9afa-a3c8af1e22d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5f0b7ccf-b1b0-40ce-abce-22917a3a65a1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_7cc6908b-9482-4166-9afa-a3c8af1e22d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_74c7f01b-967f-4d99-850b-56de7c647224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5f0b7ccf-b1b0-40ce-abce-22917a3a65a1" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_74c7f01b-967f-4d99-850b-56de7c647224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3d5b6fc4-ce70-4fe9-a227-02cb6d864803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5f0b7ccf-b1b0-40ce-abce-22917a3a65a1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3d5b6fc4-ce70-4fe9-a227-02cb6d864803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesAssumptionsDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#FairValueofFinancialAssetsandLiabilitiesAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c4ff98d3-e22f-4e82-acd2-9c17541a6658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b9df7265-626d-4e7c-9dca-6390105bfd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c4ff98d3-e22f-4e82-acd2-9c17541a6658" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b9df7265-626d-4e7c-9dca-6390105bfd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_76e17bbe-b601-4bc8-9039-d6289f9d0508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b9df7265-626d-4e7c-9dca-6390105bfd27" xlink:to="loc_us-gaap_AwardTypeAxis_76e17bbe-b601-4bc8-9039-d6289f9d0508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5747b060-8922-4045-a018-b2d3dfa4e624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_76e17bbe-b601-4bc8-9039-d6289f9d0508" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5747b060-8922-4045-a018-b2d3dfa4e624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_11a0c56a-1dac-48fb-8b15-57d3ba4317e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5747b060-8922-4045-a018-b2d3dfa4e624" xlink:to="loc_us-gaap_WarrantMember_11a0c56a-1dac-48fb-8b15-57d3ba4317e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0db36e91-ad07-4b9a-ad55-75e947a302ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b9df7265-626d-4e7c-9dca-6390105bfd27" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0db36e91-ad07-4b9a-ad55-75e947a302ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_891d92d1-f79d-413a-8082-48e1b153e2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0db36e91-ad07-4b9a-ad55-75e947a302ea" xlink:to="loc_us-gaap_SharePrice_891d92d1-f79d-413a-8082-48e1b153e2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fcb66567-2fa7-4c63-87db-d889a9f155a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0db36e91-ad07-4b9a-ad55-75e947a302ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fcb66567-2fa7-4c63-87db-d889a9f155a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_193dbd34-68fa-4e14-bd1c-26e3313be225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0db36e91-ad07-4b9a-ad55-75e947a302ea" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_193dbd34-68fa-4e14-bd1c-26e3313be225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3ada685c-3560-42c6-b3c4-a427876a2c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0db36e91-ad07-4b9a-ad55-75e947a302ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3ada685c-3560-42c6-b3c4-a427876a2c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e33fd291-cdcc-4d32-bc60-a0ab59b44b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0db36e91-ad07-4b9a-ad55-75e947a302ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e33fd291-cdcc-4d32-bc60-a0ab59b44b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_77780d0b-bf83-4435-bb08-fa971105ad73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0db36e91-ad07-4b9a-ad55-75e947a302ea" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_77780d0b-bf83-4435-bb08-fa971105ad73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesGoodwillRollforwardDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#FairValueofFinancialAssetsandLiabilitiesGoodwillRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cedec50e-fc0e-4b70-b82c-0f3cd2cf82da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_11b30248-3553-4485-ad8c-74fa9c20803c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cedec50e-fc0e-4b70-b82c-0f3cd2cf82da" xlink:to="loc_us-gaap_GoodwillGross_11b30248-3553-4485-ad8c-74fa9c20803c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_88197158-517d-4a38-94c1-a6f6e6271907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cedec50e-fc0e-4b70-b82c-0f3cd2cf82da" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_88197158-517d-4a38-94c1-a6f6e6271907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_67cc2927-3dc0-4ba3-83be-098b0e51b780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cedec50e-fc0e-4b70-b82c-0f3cd2cf82da" xlink:to="loc_us-gaap_Goodwill_67cc2927-3dc0-4ba3-83be-098b0e51b780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_98848461-1b22-41d2-98af-13ad55bdbb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cedec50e-fc0e-4b70-b82c-0f3cd2cf82da" xlink:to="loc_us-gaap_GoodwillRollForward_98848461-1b22-41d2-98af-13ad55bdbb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2d41f2a2-5724-47c4-9419-297e039a8f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_98848461-1b22-41d2-98af-13ad55bdbb52" xlink:to="loc_us-gaap_Goodwill_2d41f2a2-5724-47c4-9419-297e039a8f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9624829a-dab9-4c5e-8a40-7b85b6299499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_98848461-1b22-41d2-98af-13ad55bdbb52" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9624829a-dab9-4c5e-8a40-7b85b6299499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7dffd58f-04c9-42ec-bc96-29a97a78e96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_98848461-1b22-41d2-98af-13ad55bdbb52" xlink:to="loc_us-gaap_Goodwill_7dffd58f-04c9-42ec-bc96-29a97a78e96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#PropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6576fc62-b116-48b4-b812-092ef4c1c7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ff7ab55-01fe-45c8-99fe-31c006fb0f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6576fc62-b116-48b4-b812-092ef4c1c7f3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ff7ab55-01fe-45c8-99fe-31c006fb0f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d11d585d-cef7-4c96-89b4-9b3a33ac1bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ff7ab55-01fe-45c8-99fe-31c006fb0f17" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d11d585d-cef7-4c96-89b4-9b3a33ac1bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ab2ccdfc-694b-4abb-9bbd-0912cca5eea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d11d585d-cef7-4c96-89b4-9b3a33ac1bf0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ab2ccdfc-694b-4abb-9bbd-0912cca5eea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_240868d6-8da8-4fd4-8b91-1f37517ce3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ab2ccdfc-694b-4abb-9bbd-0912cca5eea9" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_240868d6-8da8-4fd4-8b91-1f37517ce3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d25ec4e4-43ef-4bf6-b362-469b17be72ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ab2ccdfc-694b-4abb-9bbd-0912cca5eea9" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d25ec4e4-43ef-4bf6-b362-469b17be72ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_157835e2-5a54-4640-9a4a-6ce3f9a5b6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ab2ccdfc-694b-4abb-9bbd-0912cca5eea9" xlink:to="loc_us-gaap_ComputerEquipmentMember_157835e2-5a54-4640-9a4a-6ce3f9a5b6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SoftwareMember_c28680ce-4fe8-40f8-8c09-76c371870c2d" xlink:href="xfor-20221231.xsd#xfor_SoftwareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ab2ccdfc-694b-4abb-9bbd-0912cca5eea9" xlink:to="loc_xfor_SoftwareMember_c28680ce-4fe8-40f8-8c09-76c371870c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LabEquipmentMember_c84520b6-5ac2-4cf1-9695-ea9f73929960" xlink:href="xfor-20221231.xsd#xfor_LabEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ab2ccdfc-694b-4abb-9bbd-0912cca5eea9" xlink:to="loc_xfor_LabEquipmentMember_c84520b6-5ac2-4cf1-9695-ea9f73929960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fe92628d-2606-4ab2-9245-9f95ff354b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ff7ab55-01fe-45c8-99fe-31c006fb0f17" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fe92628d-2606-4ab2-9245-9f95ff354b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d9cf8254-e816-465f-9a89-c266371240c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fe92628d-2606-4ab2-9245-9f95ff354b46" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_d9cf8254-e816-465f-9a89-c266371240c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f2607175-6e5b-4c74-8ec1-db385d825532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fe92628d-2606-4ab2-9245-9f95ff354b46" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f2607175-6e5b-4c74-8ec1-db385d825532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b98b1214-ac52-4abe-a1c1-d64cd2b9a680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fe92628d-2606-4ab2-9245-9f95ff354b46" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b98b1214-ac52-4abe-a1c1-d64cd2b9a680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_13301a43-d2f2-4899-94ba-21dafd174046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fe92628d-2606-4ab2-9245-9f95ff354b46" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_13301a43-d2f2-4899-94ba-21dafd174046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_1743318a-358e-4bbd-bd2a-9d7acb2ae18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e02c5645-444d-4eac-a3a6-1aeba0b0290c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1743318a-358e-4bbd-bd2a-9d7acb2ae18d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e02c5645-444d-4eac-a3a6-1aeba0b0290c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AccruedExternalResearchAndDevelopmentExpenses_4f2cb3b4-6c36-4b7f-994a-d4555ae9bf3a" xlink:href="xfor-20221231.xsd#xfor_AccruedExternalResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1743318a-358e-4bbd-bd2a-9d7acb2ae18d" xlink:to="loc_xfor_AccruedExternalResearchAndDevelopmentExpenses_4f2cb3b4-6c36-4b7f-994a-d4555ae9bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_1255dd0d-ab28-402e-a158-5bf117e21201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1743318a-358e-4bbd-bd2a-9d7acb2ae18d" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_1255dd0d-ab28-402e-a158-5bf117e21201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AccruedDeferredFinancingFeesCurrent_65f82566-c9f0-40e4-9723-1b59c2abbadf" xlink:href="xfor-20221231.xsd#xfor_AccruedDeferredFinancingFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1743318a-358e-4bbd-bd2a-9d7acb2ae18d" xlink:to="loc_xfor_AccruedDeferredFinancingFeesCurrent_65f82566-c9f0-40e4-9723-1b59c2abbadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cc463ce5-086c-4bf6-a248-ecb6526d1a28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1743318a-358e-4bbd-bd2a-9d7acb2ae18d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cc463ce5-086c-4bf6-a248-ecb6526d1a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2d0bfff4-8f5b-4b73-90cb-ee3c2963202f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1743318a-358e-4bbd-bd2a-9d7acb2ae18d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2d0bfff4-8f5b-4b73-90cb-ee3c2963202f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_903e995c-aa7d-401b-b4b0-575864f8fec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a4b84829-19db-4774-bacf-b94d10aebdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_903e995c-aa7d-401b-b4b0-575864f8fec4" xlink:to="loc_us-gaap_LongTermDebt_a4b84829-19db-4774-bacf-b94d10aebdec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_0d88b5f0-abd0-4fa1-87a8-842248a597be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_903e995c-aa7d-401b-b4b0-575864f8fec4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_0d88b5f0-abd0-4fa1-87a8-842248a597be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AccretionOnLongTermDebt_4a061c5c-5a61-473c-a493-905864ed54da" xlink:href="xfor-20221231.xsd#xfor_AccretionOnLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_903e995c-aa7d-401b-b4b0-575864f8fec4" xlink:to="loc_xfor_AccretionOnLongTermDebt_4a061c5c-5a61-473c-a493-905864ed54da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LongTermDebtIncludingAccretion_b9ada1f3-ad2e-4298-b5f1-4b1b434ec678" xlink:href="xfor-20221231.xsd#xfor_LongTermDebtIncludingAccretion"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_903e995c-aa7d-401b-b4b0-575864f8fec4" xlink:to="loc_xfor_LongTermDebtIncludingAccretion_b9ada1f3-ad2e-4298-b5f1-4b1b434ec678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_89beaa5e-3968-481f-a75f-64298bfd324b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_903e995c-aa7d-401b-b4b0-575864f8fec4" xlink:to="loc_us-gaap_LongTermDebtCurrent_89beaa5e-3968-481f-a75f-64298bfd324b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e5c85708-7e9b-4659-9fcc-846605d5604d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_903e995c-aa7d-401b-b4b0-575864f8fec4" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e5c85708-7e9b-4659-9fcc-846605d5604d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_01c029af-45fc-4b2c-9d10-f20eb93c37da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_15c1483a-5df6-4ef4-9ed2-538a2635d5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_01c029af-45fc-4b2c-9d10-f20eb93c37da" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_15c1483a-5df6-4ef4-9ed2-538a2635d5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b067224b-74ca-4cdd-a8b3-56a63f135861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_15c1483a-5df6-4ef4-9ed2-538a2635d5f1" xlink:to="loc_us-gaap_DebtInstrumentAxis_b067224b-74ca-4cdd-a8b3-56a63f135861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_def8f3eb-ee58-427f-a01c-d4a572c97a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b067224b-74ca-4cdd-a8b3-56a63f135861" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_def8f3eb-ee58-427f-a01c-d4a572c97a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesLoanAgreementMember_36bee044-ed9d-404f-bbcf-67af98336a27" xlink:href="xfor-20221231.xsd#xfor_HerculesLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_def8f3eb-ee58-427f-a01c-d4a572c97a04" xlink:to="loc_xfor_HerculesLoanAgreementMember_36bee044-ed9d-404f-bbcf-67af98336a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesFirstAmendedLoanAgreementMember_b702e02e-ccc7-4fa6-b04f-8c53b842ca68" xlink:href="xfor-20221231.xsd#xfor_HerculesFirstAmendedLoanAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_def8f3eb-ee58-427f-a01c-d4a572c97a04" xlink:to="loc_xfor_HerculesFirstAmendedLoanAgreementMember_b702e02e-ccc7-4fa6-b04f-8c53b842ca68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesAmendedAndRestatedLoanAgreementMember_c7757f1d-9863-4c57-be32-a1e8703ef374" xlink:href="xfor-20221231.xsd#xfor_HerculesAmendedAndRestatedLoanAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_def8f3eb-ee58-427f-a01c-d4a572c97a04" xlink:to="loc_xfor_HerculesAmendedAndRestatedLoanAgreementMember_c7757f1d-9863-4c57-be32-a1e8703ef374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesSecondAmendedLoanAgreementMember_5ecc57c0-2a16-4a1d-b330-aeb3e26b3f65" xlink:href="xfor-20221231.xsd#xfor_HerculesSecondAmendedLoanAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_def8f3eb-ee58-427f-a01c-d4a572c97a04" xlink:to="loc_xfor_HerculesSecondAmendedLoanAgreementMember_5ecc57c0-2a16-4a1d-b330-aeb3e26b3f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SecondARLoanAgreementMember_a2c4a5c8-0fe6-41df-b11f-dd9359ac2a08" xlink:href="xfor-20221231.xsd#xfor_SecondARLoanAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_def8f3eb-ee58-427f-a01c-d4a572c97a04" xlink:to="loc_xfor_SecondARLoanAgreementMember_a2c4a5c8-0fe6-41df-b11f-dd9359ac2a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3d5d6e0c-163a-419e-a05a-a4525ac28f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_15c1483a-5df6-4ef4-9ed2-538a2635d5f1" xlink:to="loc_us-gaap_CreditFacilityAxis_3d5d6e0c-163a-419e-a05a-a4525ac28f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e06421b5-1075-4471-a54c-faf9b3231708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_3d5d6e0c-163a-419e-a05a-a4525ac28f7a" xlink:to="loc_us-gaap_CreditFacilityDomain_e06421b5-1075-4471-a54c-faf9b3231708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DiscretionaryBorrowingsMember_5acb5874-baa8-487f-805f-0a3d3cf79e99" xlink:href="xfor-20221231.xsd#xfor_DiscretionaryBorrowingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e06421b5-1075-4471-a54c-faf9b3231708" xlink:to="loc_xfor_DiscretionaryBorrowingsMember_5acb5874-baa8-487f-805f-0a3d3cf79e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MinCashTestDate1Member_619cdc2c-48d5-45f8-a57f-3b755c76a4df" xlink:href="xfor-20221231.xsd#xfor_MinCashTestDate1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e06421b5-1075-4471-a54c-faf9b3231708" xlink:to="loc_xfor_MinCashTestDate1Member_619cdc2c-48d5-45f8-a57f-3b755c76a4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MinCashTestDate2Member_144bf6f1-a4c1-4ed7-a107-f9bfdfda72a1" xlink:href="xfor-20221231.xsd#xfor_MinCashTestDate2Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e06421b5-1075-4471-a54c-faf9b3231708" xlink:to="loc_xfor_MinCashTestDate2Member_144bf6f1-a4c1-4ed7-a107-f9bfdfda72a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_06b0fb03-8151-49b7-a5a6-2075a59e7067" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_15c1483a-5df6-4ef4-9ed2-538a2635d5f1" xlink:to="loc_srt_RangeAxis_06b0fb03-8151-49b7-a5a6-2075a59e7067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0be2b45c-6933-448c-8db6-35f2a0e4d867" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_06b0fb03-8151-49b7-a5a6-2075a59e7067" xlink:to="loc_srt_RangeMember_0be2b45c-6933-448c-8db6-35f2a0e4d867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a704ba0a-5711-40af-a6f4-47a1b4745133" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0be2b45c-6933-448c-8db6-35f2a0e4d867" xlink:to="loc_srt_MinimumMember_a704ba0a-5711-40af-a6f4-47a1b4745133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e46f7275-8a47-469e-9642-6ae4fd287c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_15c1483a-5df6-4ef4-9ed2-538a2635d5f1" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e46f7275-8a47-469e-9642-6ae4fd287c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_3444182d-8b43-42d8-99b8-f037cd4ec5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e46f7275-8a47-469e-9642-6ae4fd287c71" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_3444182d-8b43-42d8-99b8-f037cd4ec5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_247af9fe-a68a-4dd5-a29f-e824c64be6c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_15c1483a-5df6-4ef4-9ed2-538a2635d5f1" xlink:to="loc_srt_StatementScenarioAxis_247af9fe-a68a-4dd5-a29f-e824c64be6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3af4ae1b-0df6-4273-a266-7cccad5627c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_247af9fe-a68a-4dd5-a29f-e824c64be6c5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3af4ae1b-0df6-4273-a266-7cccad5627c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_9be782e5-6d43-435f-b90b-017e80f71402" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_3af4ae1b-0df6-4273-a266-7cccad5627c5" xlink:to="loc_srt_ScenarioForecastMember_9be782e5-6d43-435f-b90b-017e80f71402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_15c1483a-5df6-4ef4-9ed2-538a2635d5f1" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_abc1c5b0-9140-4e67-8eb2-5db9e2b1d1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_abc1c5b0-9140-4e67-8eb2-5db9e2b1d1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd2ca1a2-2c4a-4cc5-8efe-abd37db1f085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd2ca1a2-2c4a-4cc5-8efe-abd37db1f085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_2cb84a48-447d-4ad7-b376-e166eaba63b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_2cb84a48-447d-4ad7-b376-e166eaba63b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_bc4bad58-ae9a-4363-8d0f-dc42f068f8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_bc4bad58-ae9a-4363-8d0f-dc42f068f8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f79ed3c6-33a9-4694-934a-2d9cd27f7887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f79ed3c6-33a9-4694-934a-2d9cd27f7887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_f6c673fc-6ae9-4874-b2c8-2e9531f3efa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_f6c673fc-6ae9-4874-b2c8-2e9531f3efa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LineOfCreditCovenantMinimumCash_5af78d34-0adc-43ba-8c67-9705eca70fc3" xlink:href="xfor-20221231.xsd#xfor_LineOfCreditCovenantMinimumCash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_xfor_LineOfCreditCovenantMinimumCash_5af78d34-0adc-43ba-8c67-9705eca70fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2895140f-390f-4153-a793-04850734ad23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2895140f-390f-4153-a793-04850734ad23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_6403d77f-1612-4394-b508-3f07381022ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_6403d77f-1612-4394-b508-3f07381022ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DebtInstrumentPrePaymentPremiumPercentage_b871e43d-26d1-4cf4-b746-43bbee54a917" xlink:href="xfor-20221231.xsd#xfor_DebtInstrumentPrePaymentPremiumPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_xfor_DebtInstrumentPrePaymentPremiumPercentage_b871e43d-26d1-4cf4-b746-43bbee54a917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequired_5a22bdbe-f2ec-4c7f-95a4-9e67558fdc00" xlink:href="xfor-20221231.xsd#xfor_DebtInstrumentDebtCovenantMinimumCashRequired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequired_5a22bdbe-f2ec-4c7f-95a4-9e67558fdc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequiredConditionalScenario_d06c5e2e-1456-4b64-a73b-1d34cb4b2dd6" xlink:href="xfor-20221231.xsd#xfor_DebtInstrumentDebtCovenantMinimumCashRequiredConditionalScenario"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequiredConditionalScenario_d06c5e2e-1456-4b64-a73b-1d34cb4b2dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPayment_f07cda0c-7cee-4553-bce2-d09b19c2aec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPayment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_2b3db677-ea6a-404d-9b6f-8073523bead5" xlink:to="loc_us-gaap_LineOfCreditFacilityPeriodicPayment_f07cda0c-7cee-4553-bce2-d09b19c2aec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtHerculesLoanAgreementsDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LongTermDebtHerculesLoanAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtHerculesLoanAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d86f4aeb-dd00-4927-a71f-7f6060f5355b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_9bab1ef8-ab97-4aca-a530-f7b1d4defb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d86f4aeb-dd00-4927-a71f-7f6060f5355b" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_9bab1ef8-ab97-4aca-a530-f7b1d4defb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a52dc100-aa44-41c8-a765-b5a3ded34d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9bab1ef8-ab97-4aca-a530-f7b1d4defb13" xlink:to="loc_us-gaap_DebtInstrumentAxis_a52dc100-aa44-41c8-a765-b5a3ded34d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5dacefae-6cac-48ae-913f-05b2b75494b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a52dc100-aa44-41c8-a765-b5a3ded34d05" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5dacefae-6cac-48ae-913f-05b2b75494b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesLoanAgreementMember_418260e6-259b-42ea-8741-9a48c5342a23" xlink:href="xfor-20221231.xsd#xfor_HerculesLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5dacefae-6cac-48ae-913f-05b2b75494b2" xlink:to="loc_xfor_HerculesLoanAgreementMember_418260e6-259b-42ea-8741-9a48c5342a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_4916943a-a84f-49c8-b456-757d1d5787c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9bab1ef8-ab97-4aca-a530-f7b1d4defb13" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_4916943a-a84f-49c8-b456-757d1d5787c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d5e5f82c-6d58-4aa2-88a3-cc989c4d3b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_4916943a-a84f-49c8-b456-757d1d5787c0" xlink:to="loc_us-gaap_InterestExpenseDebt_d5e5f82c-6d58-4aa2-88a3-cc989c4d3b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_cc50d2ec-e9b2-4cef-978a-6176dbaf9cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_4916943a-a84f-49c8-b456-757d1d5787c0" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_cc50d2ec-e9b2-4cef-978a-6176dbaf9cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtFuturePrincipalPaymentsDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LongTermDebtFuturePrincipalPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtFuturePrincipalPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2aff4aac-f82d-4a46-9411-dc1e2372ea80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_5cbb0b54-cd6d-4489-852e-07d7fbb0ebe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2aff4aac-f82d-4a46-9411-dc1e2372ea80" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_5cbb0b54-cd6d-4489-852e-07d7fbb0ebe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_30648575-8a65-41ef-a849-9dbb7a0ee862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5cbb0b54-cd6d-4489-852e-07d7fbb0ebe2" xlink:to="loc_us-gaap_DebtInstrumentAxis_30648575-8a65-41ef-a849-9dbb7a0ee862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_088d833a-b39e-4470-bdb6-fb539fc8036b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_30648575-8a65-41ef-a849-9dbb7a0ee862" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_088d833a-b39e-4470-bdb6-fb539fc8036b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SecondARLoanAgreementMember_8d25ac23-193c-4aec-a3e8-5c701836dadb" xlink:href="xfor-20221231.xsd#xfor_SecondARLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_088d833a-b39e-4470-bdb6-fb539fc8036b" xlink:to="loc_xfor_SecondARLoanAgreementMember_8d25ac23-193c-4aec-a3e8-5c701836dadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_4bdcc4ff-85b1-490f-814a-90fbaf529225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5cbb0b54-cd6d-4489-852e-07d7fbb0ebe2" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_4bdcc4ff-85b1-490f-814a-90fbaf529225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e8b1eb70-13b2-4037-9da5-a8836fb8a780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_4bdcc4ff-85b1-490f-814a-90fbaf529225" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e8b1eb70-13b2-4037-9da5-a8836fb8a780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3c298aec-99b9-4b14-8244-38bcbf11033b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_4bdcc4ff-85b1-490f-814a-90fbaf529225" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3c298aec-99b9-4b14-8244-38bcbf11033b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0f0ea1f3-c0f4-43ca-a8e4-f1e3c53ff5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_4bdcc4ff-85b1-490f-814a-90fbaf529225" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0f0ea1f3-c0f4-43ca-a8e4-f1e3c53ff5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c0d1ed91-dbcf-4047-832e-c1809f1f6b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_4bdcc4ff-85b1-490f-814a-90fbaf529225" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c0d1ed91-dbcf-4047-832e-c1809f1f6b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LongTermDebtAndEOTPayment_7c0c0efb-8b83-457c-91e1-9b42a73fa9ea" xlink:href="xfor-20221231.xsd#xfor_LongTermDebtAndEOTPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_4bdcc4ff-85b1-490f-814a-90fbaf529225" xlink:to="loc_xfor_LongTermDebtAndEOTPayment_7c0c0efb-8b83-457c-91e1-9b42a73fa9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_30712b0b-2d20-42ea-ad8b-ed5d51f9b98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c1c9b5ed-64cc-4bab-8e6e-f3a6033e2452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_30712b0b-2d20-42ea-ad8b-ed5d51f9b98d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c1c9b5ed-64cc-4bab-8e6e-f3a6033e2452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7afa5f39-5fd5-41b8-9d6b-9ea3c20dd639" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c1c9b5ed-64cc-4bab-8e6e-f3a6033e2452" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7afa5f39-5fd5-41b8-9d6b-9ea3c20dd639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_feb630b8-1375-4c2a-b65b-9c4a29f027e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7afa5f39-5fd5-41b8-9d6b-9ea3c20dd639" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_feb630b8-1375-4c2a-b65b-9c4a29f027e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_WalthamLeaseMember_7f7503fd-b0ba-4b70-b88e-17832e0b0284" xlink:href="xfor-20221231.xsd#xfor_WalthamLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_feb630b8-1375-4c2a-b65b-9c4a29f027e5" xlink:to="loc_xfor_WalthamLeaseMember_7f7503fd-b0ba-4b70-b88e-17832e0b0284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ViennaLeaseArrangementMember_b4e54dc8-084a-4b5f-8135-42c6447d164b" xlink:href="xfor-20221231.xsd#xfor_ViennaLeaseArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_feb630b8-1375-4c2a-b65b-9c4a29f027e5" xlink:to="loc_xfor_ViennaLeaseArrangementMember_b4e54dc8-084a-4b5f-8135-42c6447d164b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AllstonLeaseMember_856ac6cd-55ef-48ed-a424-a756578a821a" xlink:href="xfor-20221231.xsd#xfor_AllstonLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_feb630b8-1375-4c2a-b65b-9c4a29f027e5" xlink:to="loc_xfor_AllstonLeaseMember_856ac6cd-55ef-48ed-a424-a756578a821a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_NewViennaLeaseMember_ff39a481-bae8-458e-a143-e801f5cf95fc" xlink:href="xfor-20221231.xsd#xfor_NewViennaLeaseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_feb630b8-1375-4c2a-b65b-9c4a29f027e5" xlink:to="loc_xfor_NewViennaLeaseMember_ff39a481-bae8-458e-a143-e801f5cf95fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c1c9b5ed-64cc-4bab-8e6e-f3a6033e2452" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CurrentOfficeSpaceUnderLeaseAgreement_b4e0f7f7-3382-4dae-a21b-ba5163f89afe" xlink:href="xfor-20221231.xsd#xfor_CurrentOfficeSpaceUnderLeaseAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_xfor_CurrentOfficeSpaceUnderLeaseAgreement_b4e0f7f7-3382-4dae-a21b-ba5163f89afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_27d3e325-02f4-4f27-b7a0-a7ccad64c3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_27d3e325-02f4-4f27-b7a0-a7ccad64c3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LesseeOperatingLeaseSecurityDepositLineOfCredit_a451c189-2387-4881-9b4f-9509ae10f081" xlink:href="xfor-20221231.xsd#xfor_LesseeOperatingLeaseSecurityDepositLineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_xfor_LesseeOperatingLeaseSecurityDepositLineOfCredit_a451c189-2387-4881-9b4f-9509ae10f081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6bdb5888-3f31-4040-bcb0-05917db9f6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_OperatingLeaseLiability_6bdb5888-3f31-4040-bcb0-05917db9f6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5f1cd51c-ba3f-4af6-8521-e2c4fee0d14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5f1cd51c-ba3f-4af6-8521-e2c4fee0d14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5166d3cc-cb73-430a-b0da-fc2f88ba128a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5166d3cc-cb73-430a-b0da-fc2f88ba128a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedOfficeSpace_2931f6ae-1fc6-449b-a601-131a3daf95bf" xlink:href="xfor-20221231.xsd#xfor_LesseeOperatingLeaseLeaseNotYetCommencedOfficeSpace"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedOfficeSpace_2931f6ae-1fc6-449b-a601-131a3daf95bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AggregateBaseRent_a9638eaa-25d3-4878-b316-7560e53069cd" xlink:href="xfor-20221231.xsd#xfor_AggregateBaseRent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_xfor_AggregateBaseRent_a9638eaa-25d3-4878-b316-7560e53069cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9decee5b-9ec7-4df8-98a1-77edb1978b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9decee5b-9ec7-4df8-98a1-77edb1978b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_5f3ef9fa-efcc-4fe1-accc-802c187f38ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_5f3ef9fa-efcc-4fe1-accc-802c187f38ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_OperatingLeaseRightOfUseAssetAmortizationTerm_009a4a0e-d766-4d9e-8a4f-dfe3173163c4" xlink:href="xfor-20221231.xsd#xfor_OperatingLeaseRightOfUseAssetAmortizationTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_xfor_OperatingLeaseRightOfUseAssetAmortizationTerm_009a4a0e-d766-4d9e-8a4f-dfe3173163c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedAmount_e0c96e5e-f591-46de-ab5b-589ceb2b099f" xlink:href="xfor-20221231.xsd#xfor_LesseeOperatingLeaseLeaseNotYetCommencedAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedAmount_e0c96e5e-f591-46de-ab5b-589ceb2b099f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_28d3f6d4-ee5d-4ce9-bb64-66c855f6a573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_OperatingLeaseCost_28d3f6d4-ee5d-4ce9-bb64-66c855f6a573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_929373f2-00d8-4b6e-8a38-024f1e41f5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_ShortTermLeaseCost_929373f2-00d8-4b6e-8a38-024f1e41f5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_7878c5d5-f588-45dc-a451-d70b2dc81016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_LeaseCost_7878c5d5-f588-45dc-a451-d70b2dc81016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_b5b7a99f-6044-44f3-acf1-2c3f89ced6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_OperatingLeasePayments_b5b7a99f-6044-44f3-acf1-2c3f89ced6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bf90884b-785f-47f3-be2f-3edf4f5deeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bf90884b-785f-47f3-be2f-3edf4f5deeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e43cf1d3-6da0-49e2-9a5f-2934d2f5de40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e43cf1d3-6da0-49e2-9a5f-2934d2f5de40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_92171440-ff8f-470d-81b7-842c8661796e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_92171440-ff8f-470d-81b7-842c8661796e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_e47c33f7-45ef-41fd-bbd9-3c6ca52f60b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d3d926f5-496e-439b-b040-a6c44fdfdcd0" xlink:to="loc_us-gaap_SubleaseIncome_e47c33f7-45ef-41fd-bbd9-3c6ca52f60b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#LeasesScheduleofComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_db1c654a-19a6-4f4f-b21b-93a4fd2ec38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_478a183f-6a3e-4442-a213-180b9e6ab0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db1c654a-19a6-4f4f-b21b-93a4fd2ec38a" xlink:to="loc_us-gaap_LeaseCostAbstract_478a183f-6a3e-4442-a213-180b9e6ab0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_18ccfc50-6278-48db-9e62-e43155a6e147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_478a183f-6a3e-4442-a213-180b9e6ab0ff" xlink:to="loc_us-gaap_OperatingLeaseCost_18ccfc50-6278-48db-9e62-e43155a6e147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_ee2d47ac-8c57-421d-a41e-4811d21cff33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_478a183f-6a3e-4442-a213-180b9e6ab0ff" xlink:to="loc_us-gaap_ShortTermLeaseCost_ee2d47ac-8c57-421d-a41e-4811d21cff33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_49c4187a-c0c6-411f-bc98-d89cb235c1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_478a183f-6a3e-4442-a213-180b9e6ab0ff" xlink:to="loc_us-gaap_LeaseCost_49c4187a-c0c6-411f-bc98-d89cb235c1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LeaseCostAdditionalInformationAbstract_1e861c3b-da0f-4cab-b4ce-447a7271d493" xlink:href="xfor-20221231.xsd#xfor_LeaseCostAdditionalInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db1c654a-19a6-4f4f-b21b-93a4fd2ec38a" xlink:to="loc_xfor_LeaseCostAdditionalInformationAbstract_1e861c3b-da0f-4cab-b4ce-447a7271d493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_05d4a079-baad-4b5d-86d9-165b45d53099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_LeaseCostAdditionalInformationAbstract_1e861c3b-da0f-4cab-b4ce-447a7271d493" xlink:to="loc_us-gaap_OperatingLeasePayments_05d4a079-baad-4b5d-86d9-165b45d53099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bf2d5d46-4916-4881-9122-cb3377b4e7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_LeaseCostAdditionalInformationAbstract_1e861c3b-da0f-4cab-b4ce-447a7271d493" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bf2d5d46-4916-4881-9122-cb3377b4e7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5e6baf7d-62d5-49e3-afe7-cc885b516b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_LeaseCostAdditionalInformationAbstract_1e861c3b-da0f-4cab-b4ce-447a7271d493" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5e6baf7d-62d5-49e3-afe7-cc885b516b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_37905f22-cb68-473c-b6df-784d7405793b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_LeaseCostAdditionalInformationAbstract_1e861c3b-da0f-4cab-b4ce-447a7271d493" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_37905f22-cb68-473c-b6df-784d7405793b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_ebf88563-0423-4a3c-8f4c-567bb2875af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_LeaseCostAdditionalInformationAbstract_1e861c3b-da0f-4cab-b4ce-447a7271d493" xlink:to="loc_us-gaap_SubleaseIncome_ebf88563-0423-4a3c-8f4c-567bb2875af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail" xlink:type="simple" xlink:href="xfor-20221231.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1ecac368-d32a-47ee-8fbd-8ad1d777a818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1ecac368-d32a-47ee-8fbd-8ad1d777a818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ddde691d-f172-447c-ae8c-f03e6f97da71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ddde691d-f172-447c-ae8c-f03e6f97da71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7320b0bb-d6d3-4635-afa3-fbc92a9a7f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7320b0bb-d6d3-4635-afa3-fbc92a9a7f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_aab2b238-b8d4-49ac-b4f6-ff2b017af9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_aab2b238-b8d4-49ac-b4f6-ff2b017af9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b6342e18-8e17-4b40-b6c9-3ce0e160fcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b6342e18-8e17-4b40-b6c9-3ce0e160fcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0ea7dd2-7222-4589-9d27-1fdc40215d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0ea7dd2-7222-4589-9d27-1fdc40215d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_dacd60e4-2815-4cf6-81de-41960f0e70e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_dacd60e4-2815-4cf6-81de-41960f0e70e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_92db0082-1c55-4338-b752-52cff032bf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9331129f-d309-4e12-8582-d7e5cc452fe8" xlink:to="loc_us-gaap_OperatingLeaseLiability_92db0082-1c55-4338-b752-52cff032bf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail_1" xlink:type="simple" xlink:href="xfor-20221231.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail_1"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PreferredandCommonStockWarrantsAdditionalInformationDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#PreferredandCommonStockWarrantsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PreferredandCommonStockWarrantsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cce992e6-f15a-4f70-ad1d-73a918a53b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e009c81b-b3b6-48e3-b9e4-485c24aa0ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cce992e6-f15a-4f70-ad1d-73a918a53b00" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e009c81b-b3b6-48e3-b9e4-485c24aa0ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_60fa7cc0-a75c-4d18-a28f-400a09271873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e009c81b-b3b6-48e3-b9e4-485c24aa0ff3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_60fa7cc0-a75c-4d18-a28f-400a09271873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cf31387d-911b-4bd9-9839-901ea4bc6bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_60fa7cc0-a75c-4d18-a28f-400a09271873" xlink:to="loc_us-gaap_EquityComponentDomain_cf31387d-911b-4bd9-9839-901ea4bc6bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassAWarrantMember_ee3a7cef-489d-4e21-a54c-d82c0f930cfe" xlink:href="xfor-20221231.xsd#xfor_ClassAWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cf31387d-911b-4bd9-9839-901ea4bc6bb1" xlink:to="loc_xfor_ClassAWarrantMember_ee3a7cef-489d-4e21-a54c-d82c0f930cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassBWarrantsMember_1979b5aa-b028-48a8-9a0b-77190abbf89d" xlink:href="xfor-20221231.xsd#xfor_ClassBWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cf31387d-911b-4bd9-9839-901ea4bc6bb1" xlink:to="loc_xfor_ClassBWarrantsMember_1979b5aa-b028-48a8-9a0b-77190abbf89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassCWarrantsMember_5a12ccec-1e0c-4e15-b84b-2d9293c942cc" xlink:href="xfor-20221231.xsd#xfor_ClassCWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cf31387d-911b-4bd9-9839-901ea4bc6bb1" xlink:to="loc_xfor_ClassCWarrantsMember_5a12ccec-1e0c-4e15-b84b-2d9293c942cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f802c389-65c0-4c3e-8a45-e369c50c32a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e009c81b-b3b6-48e3-b9e4-485c24aa0ff3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f802c389-65c0-4c3e-8a45-e369c50c32a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_d2013638-0127-493c-aa3b-222c1c099c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f802c389-65c0-4c3e-8a45-e369c50c32a6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_d2013638-0127-493c-aa3b-222c1c099c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_04269c4b-5d6b-4bd2-be98-305f9122d8e0" xlink:href="xfor-20221231.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d2013638-0127-493c-aa3b-222c1c099c7a" xlink:to="loc_xfor_PreFundedWarrantMember_04269c4b-5d6b-4bd2-be98-305f9122d8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarch232021Member_6c1d05fb-f119-4b2d-a6d7-657575affafb" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnMarch232021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d2013638-0127-493c-aa3b-222c1c099c7a" xlink:to="loc_xfor_IssuanceOnMarch232021Member_6c1d05fb-f119-4b2d-a6d7-657575affafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember_eb0af7dd-3c0e-4402-801b-c0ac0f10da1a" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d2013638-0127-493c-aa3b-222c1c099c7a" xlink:to="loc_xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember_eb0af7dd-3c0e-4402-801b-c0ac0f10da1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PrefundedWarrantsAxis_f88e79af-5077-4c15-94eb-5a1b04f61612" xlink:href="xfor-20221231.xsd#xfor_PrefundedWarrantsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e009c81b-b3b6-48e3-b9e4-485c24aa0ff3" xlink:to="loc_xfor_PrefundedWarrantsAxis_f88e79af-5077-4c15-94eb-5a1b04f61612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PrefundedWarrantsDomain_8f18b8a3-a235-476f-8738-a12a0e84d63c" xlink:href="xfor-20221231.xsd#xfor_PrefundedWarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_PrefundedWarrantsAxis_f88e79af-5077-4c15-94eb-5a1b04f61612" xlink:to="loc_xfor_PrefundedWarrantsDomain_8f18b8a3-a235-476f-8738-a12a0e84d63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FundedMember_89cb29d7-4171-48e0-a5ff-c37e6ae1abd5" xlink:href="xfor-20221231.xsd#xfor_FundedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_PrefundedWarrantsDomain_8f18b8a3-a235-476f-8738-a12a0e84d63c" xlink:to="loc_xfor_FundedMember_89cb29d7-4171-48e0-a5ff-c37e6ae1abd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_819cd663-9333-40ce-84c1-363cedc2b68f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e009c81b-b3b6-48e3-b9e4-485c24aa0ff3" xlink:to="loc_srt_RangeAxis_819cd663-9333-40ce-84c1-363cedc2b68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0e68a53b-4d67-457b-a47b-3a8196127fbd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_819cd663-9333-40ce-84c1-363cedc2b68f" xlink:to="loc_srt_RangeMember_0e68a53b-4d67-457b-a47b-3a8196127fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d17d5851-91a1-4097-8052-6d2ac4411d6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0e68a53b-4d67-457b-a47b-3a8196127fbd" xlink:to="loc_srt_MinimumMember_d17d5851-91a1-4097-8052-6d2ac4411d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df3a24c4-47cf-4ac7-b3fb-b71cf1d3c713" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0e68a53b-4d67-457b-a47b-3a8196127fbd" xlink:to="loc_srt_MaximumMember_df3a24c4-47cf-4ac7-b3fb-b71cf1d3c713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e009c81b-b3b6-48e3-b9e4-485c24aa0ff3" xlink:to="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightIssued_e52ef6fc-51ed-42a2-b0e0-01927df64f94" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:to="loc_xfor_ClassOfWarrantOrRightIssued_e52ef6fc-51ed-42a2-b0e0-01927df64f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4c1dd491-e109-4c1b-b2a2-59728187f4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4c1dd491-e109-4c1b-b2a2-59728187f4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightWarrantsExpirationPeriod_92a7d602-2806-433a-941d-249f1f27571a" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightWarrantsExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:to="loc_xfor_ClassOfWarrantOrRightWarrantsExpirationPeriod_92a7d602-2806-433a-941d-249f1f27571a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_66a4255f-db47-46c0-9222-8a971c26efc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_66a4255f-db47-46c0-9222-8a971c26efc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued_ed2cf232-3d40-4068-8137-21d802d18808" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:to="loc_xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued_ed2cf232-3d40-4068-8137-21d802d18808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_88a2448b-3c43-4885-932f-cb2b8f1f930a" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:to="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_88a2448b-3c43-4885-932f-cb2b8f1f930a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_3a556f5b-ef0d-4110-bd3c-15a073114312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_3a556f5b-ef0d-4110-bd3c-15a073114312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_92a3447d-83c2-4639-87fe-87ebb29d83d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64654b59-bdf3-43bd-808e-c7d3cce56162" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_92a3447d-83c2-4639-87fe-87ebb29d83d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PreferredandCommonStockWarrantsScheduleofOutstandingWarrantsDetail" xlink:type="simple" xlink:href="xfor-20221231.xsd#PreferredandCommonStockWarrantsScheduleofOutstandingWarrantsDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PreferredandCommonStockWarrantsScheduleofOutstandingWarrantsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_13fc90e7-6649-48bf-a65f-ee00325507a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_WarrantsRollForward_51732a59-236c-4def-bd40-20d8b4409920" xlink:href="xfor-20221231.xsd#xfor_WarrantsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_13fc90e7-6649-48bf-a65f-ee00325507a2" xlink:to="loc_xfor_WarrantsRollForward_51732a59-236c-4def-bd40-20d8b4409920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_c3046c74-9005-4510-9630-68c1cc6ed6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_WarrantsRollForward_51732a59-236c-4def-bd40-20d8b4409920" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_c3046c74-9005-4510-9630-68c1cc6ed6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightIssued_6268cf7a-2dbe-496c-be05-dc67702cb1a2" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_WarrantsRollForward_51732a59-236c-4def-bd40-20d8b4409920" xlink:to="loc_xfor_ClassOfWarrantOrRightIssued_6268cf7a-2dbe-496c-be05-dc67702cb1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightExercised_bc4b6d76-a0cf-4ee3-89d6-39b99444c65d" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_WarrantsRollForward_51732a59-236c-4def-bd40-20d8b4409920" xlink:to="loc_xfor_ClassOfWarrantOrRightExercised_bc4b6d76-a0cf-4ee3-89d6-39b99444c65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_374742dc-e55f-4491-bd2f-920473909f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_WarrantsRollForward_51732a59-236c-4def-bd40-20d8b4409920" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_374742dc-e55f-4491-bd2f-920473909f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightExpired_974bd5cf-3290-4887-800a-45dcca526f88" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightExpired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_WarrantsRollForward_51732a59-236c-4def-bd40-20d8b4409920" xlink:to="loc_xfor_ClassOfWarrantOrRightExpired_974bd5cf-3290-4887-800a-45dcca526f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_WarrantsWeightedAverageExercisePriceRollForward_1ddd041e-0fa7-4c64-91ea-0ae87397398c" xlink:href="xfor-20221231.xsd#xfor_WarrantsWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_13fc90e7-6649-48bf-a65f-ee00325507a2" xlink:to="loc_xfor_WarrantsWeightedAverageExercisePriceRollForward_1ddd041e-0fa7-4c64-91ea-0ae87397398c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightWeightedAverageExercisePrice_73c30656-9e38-4292-a00f-23231d63c38b" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_WarrantsWeightedAverageExercisePriceRollForward_1ddd041e-0fa7-4c64-91ea-0ae87397398c" xlink:to="loc_xfor_ClassOfWarrantOrRightWeightedAverageExercisePrice_73c30656-9e38-4292-a00f-23231d63c38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightWeightedAverageExercisePrice_732423b6-caf9-4c4d-8200-98cefbe9f7e3" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_WarrantsWeightedAverageExercisePriceRollForward_1ddd041e-0fa7-4c64-91ea-0ae87397398c" xlink:to="loc_xfor_ClassOfWarrantOrRightWeightedAverageExercisePrice_732423b6-caf9-4c4d-8200-98cefbe9f7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightWeightedAverageContractualTerm_bcf85144-aefb-4952-bfc7-9a758b544db1" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightWeightedAverageContractualTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_13fc90e7-6649-48bf-a65f-ee00325507a2" xlink:to="loc_xfor_ClassOfWarrantOrRightWeightedAverageContractualTerm_bcf85144-aefb-4952-bfc7-9a758b544db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_e88c2da5-b992-4f78-85d5-63372064779c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_13fc90e7-6649-48bf-a65f-ee00325507a2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_e88c2da5-b992-4f78-85d5-63372064779c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f540be8f-f36f-490c-a5c6-61bf60432822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e88c2da5-b992-4f78-85d5-63372064779c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f540be8f-f36f-490c-a5c6-61bf60432822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_9ed043a1-4f4c-4f79-a7f5-83d8b8f036b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f540be8f-f36f-490c-a5c6-61bf60432822" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_9ed043a1-4f4c-4f79-a7f5-83d8b8f036b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember_15d3a8ff-2bba-435a-bbd1-91a720d60335" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_9ed043a1-4f4c-4f79-a7f5-83d8b8f036b0" xlink:to="loc_xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember_15d3a8ff-2bba-435a-bbd1-91a720d60335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_a19a97bc-696b-4bf4-badd-f3a03708ba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e88c2da5-b992-4f78-85d5-63372064779c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_a19a97bc-696b-4bf4-badd-f3a03708ba9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_b1707fb1-e43a-47e5-9932-02b9dfb22ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a19a97bc-696b-4bf4-badd-f3a03708ba9c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_b1707fb1-e43a-47e5-9932-02b9dfb22ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3c565032-4e0a-456f-b1df-45086358a287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a19a97bc-696b-4bf4-badd-f3a03708ba9c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3c565032-4e0a-456f-b1df-45086358a287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PreferredandCommonStockWarrantsSummaryofOutstandingWarrantstoPurchaseSharesofCommonStockDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#PreferredandCommonStockWarrantsSummaryofOutstandingWarrantstoPurchaseSharesofCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PreferredandCommonStockWarrantsSummaryofOutstandingWarrantstoPurchaseSharesofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fa14e73a-b860-4455-8dc0-d1e2065d6b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_dab92d30-37bd-4772-b946-0df7b80996e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fa14e73a-b860-4455-8dc0-d1e2065d6b87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_dab92d30-37bd-4772-b946-0df7b80996e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5375cc2f-485c-4d78-9c64-204e8a027162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_dab92d30-37bd-4772-b946-0df7b80996e4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5375cc2f-485c-4d78-9c64-204e8a027162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5375cc2f-485c-4d78-9c64-204e8a027162" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnOctoberTwentyFiveTwoThousandSixteenMember_f8fa1752-3a99-429f-8836-5f7bf6f7ea96" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnOctoberTwentyFiveTwoThousandSixteenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnOctoberTwentyFiveTwoThousandSixteenMember_f8fa1752-3a99-429f-8836-5f7bf6f7ea96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnDecemberTwentyEightTwoThousandSeventeenOneMember_eca9196c-d16e-41ef-8ddf-ad22c6f758a9" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnDecemberTwentyEightTwoThousandSeventeenOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnDecemberTwentyEightTwoThousandSeventeenOneMember_eca9196c-d16e-41ef-8ddf-ad22c6f758a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnSeptemberTwelveTwoThousandEighteenOneMember_7294c086-47d4-4672-9a4a-a4a1ad4f0bca" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnSeptemberTwelveTwoThousandEighteenOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnSeptemberTwelveTwoThousandEighteenOneMember_7294c086-47d4-4672-9a4a-a4a1ad4f0bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnOctoberNineteenTwoThousandEighteenMember_e682cfe2-5813-4889-9561-2da075e91c27" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnOctoberNineteenTwoThousandEighteenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnOctoberNineteenTwoThousandEighteenMember_e682cfe2-5813-4889-9561-2da075e91c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarchThirteenTwoThousandNineteenMember_7cd8a42a-791a-4674-b3cb-7e7273952e75" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnMarchThirteenTwoThousandNineteenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnMarchThirteenTwoThousandNineteenMember_7cd8a42a-791a-4674-b3cb-7e7273952e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnAprilSixteenTwoThousandNineteenMember_59e1cc42-2ce2-4e45-8a7e-8f132ef14431" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnAprilSixteenTwoThousandNineteenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnAprilSixteenTwoThousandNineteenMember_59e1cc42-2ce2-4e45-8a7e-8f132ef14431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember_ac2d21cc-7bfb-4ee6-8d20-222a4abc3b77" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember_ac2d21cc-7bfb-4ee6-8d20-222a4abc3b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarch232021Member_ff550927-197b-4f83-a839-556ba743ac9f" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnMarch232021Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnMarch232021Member_ff550927-197b-4f83-a839-556ba743ac9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember_45c7f2c1-5c6d-4b2e-8e4b-57ad4808573d" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember_45c7f2c1-5c6d-4b2e-8e4b-57ad4808573d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarch32022Member_681b096c-81cd-4266-a201-a3a63822211a" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnMarch32022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnMarch32022Member_681b096c-81cd-4266-a201-a3a63822211a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnJuly20221Member_ecc97f43-3738-4ef4-9351-e532260aad6f" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnJuly20221Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnJuly20221Member_ecc97f43-3738-4ef4-9351-e532260aad6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnJuly620222Member_51c9c85c-2b94-4308-a897-87fc1d66be0e" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnJuly620222Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnJuly620222Member_51c9c85c-2b94-4308-a897-87fc1d66be0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnDecember92022Member_4d1ae51d-44f5-4ab6-844d-cbbbe2ea1e61" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnDecember92022Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnDecember92022Member_4d1ae51d-44f5-4ab6-844d-cbbbe2ea1e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnDecember920222Member_6a92f1f0-d950-4e6e-b561-a47ed020ad50" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnDecember920222Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_IssuanceOnDecember920222Member_6a92f1f0-d950-4e6e-b561-a47ed020ad50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_fb9152db-e7a5-4f32-9e24-f9486452e48a" xlink:href="xfor-20221231.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3464d542-7d14-490f-b4b9-f222975dcb58" xlink:to="loc_xfor_PreFundedWarrantMember_fb9152db-e7a5-4f32-9e24-f9486452e48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PrefundedWarrantsAxis_a72bfd89-a38c-453c-bb09-f2f8dd130c8f" xlink:href="xfor-20221231.xsd#xfor_PrefundedWarrantsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_dab92d30-37bd-4772-b946-0df7b80996e4" xlink:to="loc_xfor_PrefundedWarrantsAxis_a72bfd89-a38c-453c-bb09-f2f8dd130c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PrefundedWarrantsDomain_25371b3c-b33b-4488-978f-046b2cbc1984" xlink:href="xfor-20221231.xsd#xfor_PrefundedWarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_PrefundedWarrantsAxis_a72bfd89-a38c-453c-bb09-f2f8dd130c8f" xlink:to="loc_xfor_PrefundedWarrantsDomain_25371b3c-b33b-4488-978f-046b2cbc1984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FundedMember_d1d95900-a022-429f-8f64-9d23697af773" xlink:href="xfor-20221231.xsd#xfor_FundedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_PrefundedWarrantsDomain_25371b3c-b33b-4488-978f-046b2cbc1984" xlink:to="loc_xfor_FundedMember_d1d95900-a022-429f-8f64-9d23697af773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_5d7d9771-ebeb-4649-83f5-6a527c28bf4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_dab92d30-37bd-4772-b946-0df7b80996e4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_5d7d9771-ebeb-4649-83f5-6a527c28bf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_455c0503-6950-4977-97a1-f35b35447f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5d7d9771-ebeb-4649-83f5-6a527c28bf4f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_455c0503-6950-4977-97a1-f35b35447f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c956ffb8-8476-4279-aeaf-4cd6edbe07a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5d7d9771-ebeb-4649-83f5-6a527c28bf4f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c956ffb8-8476-4279-aeaf-4cd6edbe07a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued_c2d10035-cadb-4cdc-afc4-ea7115d1406d" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5d7d9771-ebeb-4649-83f5-6a527c28bf4f" xlink:to="loc_xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued_c2d10035-cadb-4cdc-afc4-ea7115d1406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_388fbe5c-b3e8-4f75-b042-63b2862cb2a3" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5d7d9771-ebeb-4649-83f5-6a527c28bf4f" xlink:to="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_388fbe5c-b3e8-4f75-b042-63b2862cb2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommonStockRedeemableCommonStockandConvertiblePreferredStockconvertedtoCommonStockAdditionalInformationDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#CommonStockRedeemableCommonStockandConvertiblePreferredStockconvertedtoCommonStockAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommonStockRedeemableCommonStockandConvertiblePreferredStockconvertedtoCommonStockAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cbe8e55a-5dec-4f49-8735-a78a5a37b266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cbe8e55a-5dec-4f49-8735-a78a5a37b266" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_1e65ea79-44ed-4caa-bb2c-3f76696a70fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_srt_TitleOfIndividualAxis_1e65ea79-44ed-4caa-bb2c-3f76696a70fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c27f9301-bc6c-4d03-a9b5-3fa5161bbfa9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_1e65ea79-44ed-4caa-bb2c-3f76696a70fa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c27f9301-bc6c-4d03-a9b5-3fa5161bbfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SalesAgentsMember_c4cb13d5-d0de-46ff-b50e-33650cfb6584" xlink:href="xfor-20221231.xsd#xfor_SalesAgentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c27f9301-bc6c-4d03-a9b5-3fa5161bbfa9" xlink:to="loc_xfor_SalesAgentsMember_c4cb13d5-d0de-46ff-b50e-33650cfb6584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_eb27f4b3-ac0e-41ce-8dbf-7f9aa2495073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_eb27f4b3-ac0e-41ce-8dbf-7f9aa2495073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_08333418-57e2-4cf1-8228-8abf56f5a274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_eb27f4b3-ac0e-41ce-8dbf-7f9aa2495073" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_08333418-57e2-4cf1-8228-8abf56f5a274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_49085ba9-3ed7-4c02-83fe-8a4a5cae2d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_08333418-57e2-4cf1-8228-8abf56f5a274" xlink:to="loc_us-gaap_CommonStockMember_49085ba9-3ed7-4c02-83fe-8a4a5cae2d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e6e0b39f-86c1-4a33-afe5-5427cc57cf76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e6e0b39f-86c1-4a33-afe5-5427cc57cf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1eec194d-06b4-42d0-ab01-960264536cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e6e0b39f-86c1-4a33-afe5-5427cc57cf76" xlink:to="loc_us-gaap_EquityComponentDomain_1eec194d-06b4-42d0-ab01-960264536cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarch232021Member_6f87b6f2-1da5-455d-9b52-0d5f7429cdf7" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnMarch232021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1eec194d-06b4-42d0-ab01-960264536cdc" xlink:to="loc_xfor_IssuanceOnMarch232021Member_6f87b6f2-1da5-455d-9b52-0d5f7429cdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_bec1e3aa-c5c5-441f-a049-f033b77b2a25" xlink:href="xfor-20221231.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1eec194d-06b4-42d0-ab01-960264536cdc" xlink:to="loc_xfor_PreFundedWarrantMember_bec1e3aa-c5c5-441f-a049-f033b77b2a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_Q12022PIPEMember_da0da774-708f-4c7d-be1a-1ce7e2b102bb" xlink:href="xfor-20221231.xsd#xfor_Q12022PIPEMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1eec194d-06b4-42d0-ab01-960264536cdc" xlink:to="loc_xfor_Q12022PIPEMember_da0da774-708f-4c7d-be1a-1ce7e2b102bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_Q22022PrivatePlacementMember_b904697c-b532-4625-b597-34934b873784" xlink:href="xfor-20221231.xsd#xfor_Q22022PrivatePlacementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1eec194d-06b4-42d0-ab01-960264536cdc" xlink:to="loc_xfor_Q22022PrivatePlacementMember_b904697c-b532-4625-b597-34934b873784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_Q42022PublicOfferingMember_561dcf70-a608-4904-abb8-eee2fe6397fc" xlink:href="xfor-20221231.xsd#xfor_Q42022PublicOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1eec194d-06b4-42d0-ab01-960264536cdc" xlink:to="loc_xfor_Q42022PublicOfferingMember_561dcf70-a608-4904-abb8-eee2fe6397fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_398aa124-6b22-4844-aca0-88ccec615be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_398aa124-6b22-4844-aca0-88ccec615be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d722f5f1-3467-4b3e-88fe-c953d01113b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_398aa124-6b22-4844-aca0-88ccec615be5" xlink:to="loc_us-gaap_ClassOfStockDomain_d722f5f1-3467-4b3e-88fe-c953d01113b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_c66f4d9d-e459-4042-a3fa-92eda2924907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d722f5f1-3467-4b3e-88fe-c953d01113b1" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_c66f4d9d-e459-4042-a3fa-92eda2924907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_RedeemableCommonStockMember_9e562d48-f470-47d1-a2da-aa40163b9ca4" xlink:href="xfor-20221231.xsd#xfor_RedeemableCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d722f5f1-3467-4b3e-88fe-c953d01113b1" xlink:to="loc_xfor_RedeemableCommonStockMember_9e562d48-f470-47d1-a2da-aa40163b9ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_24cad8e6-525d-485c-b9c1-1ed56f7dcaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_24cad8e6-525d-485c-b9c1-1ed56f7dcaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_37d1852b-ff4f-41dd-b3c2-e3df643c9e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_24cad8e6-525d-485c-b9c1-1ed56f7dcaaa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_37d1852b-ff4f-41dd-b3c2-e3df643c9e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarch232021Member_497ba9f2-bca7-4d5b-81a2-0ca695cb684e" xlink:href="xfor-20221231.xsd#xfor_IssuanceOnMarch232021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_37d1852b-ff4f-41dd-b3c2-e3df643c9e48" xlink:to="loc_xfor_IssuanceOnMarch232021Member_497ba9f2-bca7-4d5b-81a2-0ca695cb684e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassCWarrantsMember_04d70fcb-5ff0-41c9-9358-b17f319fe448" xlink:href="xfor-20221231.xsd#xfor_ClassCWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_37d1852b-ff4f-41dd-b3c2-e3df643c9e48" xlink:to="loc_xfor_ClassCWarrantsMember_04d70fcb-5ff0-41c9-9358-b17f319fe448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_f34ec6ee-b7db-4b46-ae1b-ac04cf94da80" xlink:href="xfor-20221231.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_37d1852b-ff4f-41dd-b3c2-e3df643c9e48" xlink:to="loc_xfor_PreFundedWarrantMember_f34ec6ee-b7db-4b46-ae1b-ac04cf94da80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PrefundedWarrantsAxis_3cd00933-0efd-4d17-9d2d-ea16dc382835" xlink:href="xfor-20221231.xsd#xfor_PrefundedWarrantsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_xfor_PrefundedWarrantsAxis_3cd00933-0efd-4d17-9d2d-ea16dc382835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PrefundedWarrantsDomain_5d5f8908-b507-43f0-9190-fb1955260504" xlink:href="xfor-20221231.xsd#xfor_PrefundedWarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_PrefundedWarrantsAxis_3cd00933-0efd-4d17-9d2d-ea16dc382835" xlink:to="loc_xfor_PrefundedWarrantsDomain_5d5f8908-b507-43f0-9190-fb1955260504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FundedMember_d7142410-ebc3-4071-ba2f-2f42da4506ef" xlink:href="xfor-20221231.xsd#xfor_FundedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_PrefundedWarrantsDomain_5d5f8908-b507-43f0-9190-fb1955260504" xlink:to="loc_xfor_FundedMember_d7142410-ebc3-4071-ba2f-2f42da4506ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7783145c-747b-45ff-8d54-aa1b5d3cf1ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_srt_CounterpartyNameAxis_7783145c-747b-45ff-8d54-aa1b5d3cf1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f2971f2-bee2-4b91-b0ac-21e0d4685e4f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_7783145c-747b-45ff-8d54-aa1b5d3cf1ca" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f2971f2-bee2-4b91-b0ac-21e0d4685e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LincolnParkCapitalFundLLCMember_0147178e-d474-4e92-aa68-2873d5955ff5" xlink:href="xfor-20221231.xsd#xfor_LincolnParkCapitalFundLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f2971f2-bee2-4b91-b0ac-21e0d4685e4f" xlink:to="loc_xfor_LincolnParkCapitalFundLLCMember_0147178e-d474-4e92-aa68-2873d5955ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_32db2103-7253-49ca-96dd-cd5ade368e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_32db2103-7253-49ca-96dd-cd5ade368e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a823e167-9103-41af-8e54-bbddc7a79e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_32db2103-7253-49ca-96dd-cd5ade368e60" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a823e167-9103-41af-8e54-bbddc7a79e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityUnitPurchaseAgreementsMember_2d594839-c780-4797-84c9-13e8f1987253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a823e167-9103-41af-8e54-bbddc7a79e79" xlink:to="loc_us-gaap_EquityUnitPurchaseAgreementsMember_2d594839-c780-4797-84c9-13e8f1987253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a9bbf032-7538-4035-8f38-866f42cf650b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_us-gaap_AwardTypeAxis_a9bbf032-7538-4035-8f38-866f42cf650b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3e88c713-8a57-455a-af6a-e76379fc6dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a9bbf032-7538-4035-8f38-866f42cf650b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3e88c713-8a57-455a-af6a-e76379fc6dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_74fb6d40-0b12-4f77-a229-55c3fa934423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3e88c713-8a57-455a-af6a-e76379fc6dd8" xlink:to="loc_us-gaap_WarrantMember_74fb6d40-0b12-4f77-a229-55c3fa934423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_9d16f1d1-f0bb-448c-8cc6-874559ad9a30" xlink:href="xfor-20221231.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3e88c713-8a57-455a-af6a-e76379fc6dd8" xlink:to="loc_xfor_PreFundedWarrantMember_9d16f1d1-f0bb-448c-8cc6-874559ad9a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_781005d7-7920-461b-9170-34886a27abc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_781005d7-7920-461b-9170-34886a27abc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_843ed387-18ff-4dff-89bb-3af4f40a7171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_781005d7-7920-461b-9170-34886a27abc7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_843ed387-18ff-4dff-89bb-3af4f40a7171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_e4d8816b-2f4d-4738-b515-50d2841f067f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_843ed387-18ff-4dff-89bb-3af4f40a7171" xlink:to="loc_us-gaap_WarrantMember_e4d8816b-2f4d-4738-b515-50d2841f067f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_33d2a890-5ee4-4dce-a387-46fd7c45664c" xlink:to="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_98feec5d-707a-450b-857e-242c221a9d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_98feec5d-707a-450b-857e-242c221a9d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9683c409-bcf6-4edf-8cc1-b20531d407b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9683c409-bcf6-4edf-8cc1-b20531d407b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_76c0b1a1-6db8-4ecb-a83f-4c975993111c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_DividendsCommonStock_76c0b1a1-6db8-4ecb-a83f-4c975993111c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SaleOfStockNumberOfSharesAuthorizedInTransactionAmount_dea0a4db-f142-42e7-af23-2a1c29da0eb4" xlink:href="xfor-20221231.xsd#xfor_SaleOfStockNumberOfSharesAuthorizedInTransactionAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_xfor_SaleOfStockNumberOfSharesAuthorizedInTransactionAmount_dea0a4db-f142-42e7-af23-2a1c29da0eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_fe623c37-2787-46c3-8548-c05d13663098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_fe623c37-2787-46c3-8548-c05d13663098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e25274f1-b341-4372-8eb1-cb8ada0e298a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e25274f1-b341-4372-8eb1-cb8ada0e298a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e4ce4a8e-f6f9-4f61-9432-7b99eb4b21a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e4ce4a8e-f6f9-4f61-9432-7b99eb4b21a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4aeafe9e-985c-4f3d-83c0-c1ae2c60ece3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4aeafe9e-985c-4f3d-83c0-c1ae2c60ece3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ProceedsFromIssuanceOfCommonStockBeforeUnderwritingDiscountsCommissionsAndOtherExpenses_3b89692a-eef2-4b26-98b5-d44e793df577" xlink:href="xfor-20221231.xsd#xfor_ProceedsFromIssuanceOfCommonStockBeforeUnderwritingDiscountsCommissionsAndOtherExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_xfor_ProceedsFromIssuanceOfCommonStockBeforeUnderwritingDiscountsCommissionsAndOtherExpenses_3b89692a-eef2-4b26-98b5-d44e793df577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_be1e7fca-b88e-4a47-a3f7-e8484fa45eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_be1e7fca-b88e-4a47-a3f7-e8484fa45eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_63b72a6d-795a-4abd-823a-892183e3cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_63b72a6d-795a-4abd-823a-892183e3cb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SaleOfStockPurchaseAgreementTerm_f05e20a3-d49e-4a75-8141-9660ddfeb90b" xlink:href="xfor-20221231.xsd#xfor_SaleOfStockPurchaseAgreementTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_xfor_SaleOfStockPurchaseAgreementTerm_f05e20a3-d49e-4a75-8141-9660ddfeb90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SaleOfStockPurchaseAgreementSharesIssued_8c0d7e37-9dd0-41d1-87da-986b79e1f0e9" xlink:href="xfor-20221231.xsd#xfor_SaleOfStockPurchaseAgreementSharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_xfor_SaleOfStockPurchaseAgreementSharesIssued_8c0d7e37-9dd0-41d1-87da-986b79e1f0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PurchaseAgreementSharesPurchased_55ce86b2-c29a-4165-ae59-49b9a3d470e2" xlink:href="xfor-20221231.xsd#xfor_PurchaseAgreementSharesPurchased"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_xfor_PurchaseAgreementSharesPurchased_55ce86b2-c29a-4165-ae59-49b9a3d470e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_12c4558b-b284-4c30-aaa1-23ba53138fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_12c4558b-b284-4c30-aaa1-23ba53138fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSecuritiesPurchasedUnderAgreementsToResell_77ba9a6c-dcd2-4bf7-972d-4e40d46f0316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForSecuritiesPurchasedUnderAgreementsToResell"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_PaymentsForSecuritiesPurchasedUnderAgreementsToResell_77ba9a6c-dcd2-4bf7-972d-4e40d46f0316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_650e984d-67ec-4fa2-a9c5-3aa81f1738f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_650e984d-67ec-4fa2-a9c5-3aa81f1738f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_a97b391b-6e50-49d3-bd6d-3320bf05b0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_a97b391b-6e50-49d3-bd6d-3320bf05b0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2164d985-dcea-4efe-8861-93f91559ea65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2164d985-dcea-4efe-8861-93f91559ea65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_5946832f-3ddf-47cf-8edb-6b44de04fcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_5946832f-3ddf-47cf-8edb-6b44de04fcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_a6777b50-836d-45a4-8eac-aff8feceafe0" xlink:href="xfor-20221231.xsd#xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_a6777b50-836d-45a4-8eac-aff8feceafe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c26ab6c5-fa9d-435f-b079-ad68311d3a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c26ab6c5-fa9d-435f-b079-ad68311d3a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_WarrantsAndRightsOutstandingTransactionFees_ef488770-615b-4bcc-bca9-499ae18909cc" xlink:href="xfor-20221231.xsd#xfor_WarrantsAndRightsOutstandingTransactionFees"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_xfor_WarrantsAndRightsOutstandingTransactionFees_ef488770-615b-4bcc-bca9-499ae18909cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f4aabd65-9f4a-4840-bd23-62c19a928fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f9d55dc9-a7e9-43dc-8503-198716e7a5a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f4aabd65-9f4a-4840-bd23-62c19a928fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2d7ac59d-bd35-4cca-ae6c-ceede35109dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a02c5842-dd35-4aa6-a438-19c74f86ce1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2d7ac59d-bd35-4cca-ae6c-ceede35109dc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a02c5842-dd35-4aa6-a438-19c74f86ce1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_379019d8-1400-4c9f-8223-e21f2a0a9b93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a02c5842-dd35-4aa6-a438-19c74f86ce1a" xlink:to="loc_srt_RangeAxis_379019d8-1400-4c9f-8223-e21f2a0a9b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2d97b6a4-8d9a-46fc-be8a-1b4fd01042c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_379019d8-1400-4c9f-8223-e21f2a0a9b93" xlink:to="loc_srt_RangeMember_2d97b6a4-8d9a-46fc-be8a-1b4fd01042c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_657d5239-f283-4a69-94a7-f870413fc2ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2d97b6a4-8d9a-46fc-be8a-1b4fd01042c0" xlink:to="loc_srt_MinimumMember_657d5239-f283-4a69-94a7-f870413fc2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6420b4ab-8895-4f19-a4db-492a7953023e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2d97b6a4-8d9a-46fc-be8a-1b4fd01042c0" xlink:to="loc_srt_MaximumMember_6420b4ab-8895-4f19-a4db-492a7953023e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5155ebd4-244a-4c83-946d-29e6a7d43c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a02c5842-dd35-4aa6-a438-19c74f86ce1a" xlink:to="loc_us-gaap_PlanNameAxis_5155ebd4-244a-4c83-946d-29e6a7d43c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77219776-4bd7-435a-9ead-373e5687f602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5155ebd4-244a-4c83-946d-29e6a7d43c09" xlink:to="loc_us-gaap_PlanNameDomain_77219776-4bd7-435a-9ead-373e5687f602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TwoThousandSeventeenEquityIncentivePlanMember_76ca2f6e-a816-4191-a461-3caa1f3cb179" xlink:href="xfor-20221231.xsd#xfor_TwoThousandSeventeenEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_77219776-4bd7-435a-9ead-373e5687f602" xlink:to="loc_xfor_TwoThousandSeventeenEquityIncentivePlanMember_76ca2f6e-a816-4191-a461-3caa1f3cb179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TwoThousandNineteenEquityIncentivePlanMember_3f2a8eb5-1db7-4c82-b944-b2e9f025fd7a" xlink:href="xfor-20221231.xsd#xfor_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_77219776-4bd7-435a-9ead-373e5687f602" xlink:to="loc_xfor_TwoThousandNineteenEquityIncentivePlanMember_3f2a8eb5-1db7-4c82-b944-b2e9f025fd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_A2015EquityIncentivePlanMember_23148c1e-9132-4e6b-bb7f-579c4f6612c4" xlink:href="xfor-20221231.xsd#xfor_A2015EquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_77219776-4bd7-435a-9ead-373e5687f602" xlink:to="loc_xfor_A2015EquityIncentivePlanMember_23148c1e-9132-4e6b-bb7f-579c4f6612c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_100a4ca9-b6f7-4013-9cb9-7893b6c8aa86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a02c5842-dd35-4aa6-a438-19c74f86ce1a" xlink:to="loc_us-gaap_AwardTypeAxis_100a4ca9-b6f7-4013-9cb9-7893b6c8aa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1915897f-d6dc-4e7c-9393-2f1a7b5daf82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_100a4ca9-b6f7-4013-9cb9-7893b6c8aa86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1915897f-d6dc-4e7c-9393-2f1a7b5daf82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e34d635f-2e01-4ab4-8ce8-f883ed669064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1915897f-d6dc-4e7c-9393-2f1a7b5daf82" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e34d635f-2e01-4ab4-8ce8-f883ed669064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IncentiveStockOptionsAndRestrictedStockAwardsMember_4aa01a5d-8fcf-479b-8a6a-d3b9de2c28b4" xlink:href="xfor-20221231.xsd#xfor_IncentiveStockOptionsAndRestrictedStockAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1915897f-d6dc-4e7c-9393-2f1a7b5daf82" xlink:to="loc_xfor_IncentiveStockOptionsAndRestrictedStockAwardsMember_4aa01a5d-8fcf-479b-8a6a-d3b9de2c28b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_NonStatutoryOptionsMember_5331e1b8-c45f-4af9-9367-c3c07d31aa95" xlink:href="xfor-20221231.xsd#xfor_NonStatutoryOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1915897f-d6dc-4e7c-9393-2f1a7b5daf82" xlink:to="loc_xfor_NonStatutoryOptionsMember_5331e1b8-c45f-4af9-9367-c3c07d31aa95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_733b39ce-d046-40c7-9d3f-867ea61552f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1915897f-d6dc-4e7c-9393-2f1a7b5daf82" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_733b39ce-d046-40c7-9d3f-867ea61552f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_8e3969ff-e0f8-4d1a-9f5f-ab4e98f61606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1915897f-d6dc-4e7c-9393-2f1a7b5daf82" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_8e3969ff-e0f8-4d1a-9f5f-ab4e98f61606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_355b84b0-db2d-47c6-bc5c-3a0730e0ef7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a02c5842-dd35-4aa6-a438-19c74f86ce1a" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_355b84b0-db2d-47c6-bc5c-3a0730e0ef7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_aea09e17-c6ce-42a7-9662-370aceab3b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_355b84b0-db2d-47c6-bc5c-3a0730e0ef7f" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_aea09e17-c6ce-42a7-9662-370aceab3b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_EmployeeStockPurchasePlansMember_7ebb673d-db11-476d-9533-f96ccc1f5706" xlink:href="xfor-20221231.xsd#xfor_EmployeeStockPurchasePlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_aea09e17-c6ce-42a7-9662-370aceab3b11" xlink:to="loc_xfor_EmployeeStockPurchasePlansMember_7ebb673d-db11-476d-9533-f96ccc1f5706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a02c5842-dd35-4aa6-a438-19c74f86ce1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceMaximumPercentageOfFairMarketValueOfCommonStock_5a5b10d0-8998-4e45-94a5-92411f32291c" xlink:href="xfor-20221231.xsd#xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceMaximumPercentageOfFairMarketValueOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceMaximumPercentageOfFairMarketValueOfCommonStock_5a5b10d0-8998-4e45-94a5-92411f32291c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c424ed38-ef88-4632-8f9a-afc1bf141db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c424ed38-ef88-4632-8f9a-afc1bf141db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2dda08d9-9382-415a-bfe3-95f3078e8e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2dda08d9-9382-415a-bfe3-95f3078e8e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_994ddb07-4456-4f61-990c-89ed94c83851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_994ddb07-4456-4f61-990c-89ed94c83851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2e7a3512-6331-4bae-9ccd-4620488592e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2e7a3512-6331-4bae-9ccd-4620488592e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_b82a42db-c774-4d17-b591-39f1d12b865d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_b82a42db-c774-4d17-b591-39f1d12b865d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e4aa5ab9-1709-48ab-94c6-1a19a1082a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e4aa5ab9-1709-48ab-94c6-1a19a1082a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c245744f-0769-46fb-81e3-120652e9b4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c245744f-0769-46fb-81e3-120652e9b4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_75d86bda-37cb-4a86-84ce-3c9564b3271b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_75d86bda-37cb-4a86-84ce-3c9564b3271b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0a18d0a1-e301-4e56-9a23-9035be96ecd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0a18d0a1-e301-4e56-9a23-9035be96ecd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsGrantInPeriodWeightedAverageGrantDateFairValue_ad144b58-24de-4272-be0f-593b23486765" xlink:href="xfor-20221231.xsd#xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsGrantInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsGrantInPeriodWeightedAverageGrantDateFairValue_ad144b58-24de-4272-be0f-593b23486765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5e581691-f546-452e-a50a-cc5153f2a68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5e581691-f546-452e-a50a-cc5153f2a68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_758ad5ee-b4bb-48ef-91ec-491d7f261a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_758ad5ee-b4bb-48ef-91ec-491d7f261a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0d45daeb-7f45-41cb-b08d-abbd20d06782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0d45daeb-7f45-41cb-b08d-abbd20d06782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6492efad-0a68-4994-9fba-4c7cbba688ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6492efad-0a68-4994-9fba-4c7cbba688ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8696077f-1236-40cf-8c20-2334ae030646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d6a45f41-1253-4cb7-9072-58b809e9715a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8696077f-1236-40cf-8c20-2334ae030646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockOptionActivityDetail" xlink:type="simple" xlink:href="xfor-20221231.xsd#StockBasedCompensationSummaryofStockOptionActivityDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockOptionActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3ff86bd-3b05-49fa-bdfc-902819a57758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3ff86bd-3b05-49fa-bdfc-902819a57758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1febae1a-cc31-4e98-970d-2d9634803d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3ff86bd-3b05-49fa-bdfc-902819a57758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1febae1a-cc31-4e98-970d-2d9634803d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_281009e3-9cff-45c9-9650-69fae332191d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3ff86bd-3b05-49fa-bdfc-902819a57758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_281009e3-9cff-45c9-9650-69fae332191d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_51353585-011d-4658-8d97-16e67816a544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3ff86bd-3b05-49fa-bdfc-902819a57758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_51353585-011d-4658-8d97-16e67816a544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6f4cb4c2-bd26-417a-9fe4-d78090c3c047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3ff86bd-3b05-49fa-bdfc-902819a57758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6f4cb4c2-bd26-417a-9fe4-d78090c3c047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ed30c927-1273-42ca-a6ff-50826ed57a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ed30c927-1273-42ca-a6ff-50826ed57a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_213d2abb-7175-456c-9916-721f9d6aeb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_213d2abb-7175-456c-9916-721f9d6aeb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5805b57c-efe6-4faf-a59b-57d433b5fcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5805b57c-efe6-4faf-a59b-57d433b5fcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1597345-4058-49d4-8cf7-ec237586ab64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5805b57c-efe6-4faf-a59b-57d433b5fcbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1597345-4058-49d4-8cf7-ec237586ab64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a7382e32-7db5-46b5-999e-8e06ee51c0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5805b57c-efe6-4faf-a59b-57d433b5fcbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a7382e32-7db5-46b5-999e-8e06ee51c0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_263e6027-139a-4e47-9a2c-3cd753e3fc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5805b57c-efe6-4faf-a59b-57d433b5fcbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_263e6027-139a-4e47-9a2c-3cd753e3fc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7e79e748-02fb-47b9-976a-f5a7c6a2399b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5805b57c-efe6-4faf-a59b-57d433b5fcbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7e79e748-02fb-47b9-976a-f5a7c6a2399b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ee1324bc-1ff3-4853-8e16-ac5fac6f5ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ee1324bc-1ff3-4853-8e16-ac5fac6f5ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_e618f836-8ee6-4242-aac6-b1a954457b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_e618f836-8ee6-4242-aac6-b1a954457b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageContractualTermAbstract_41b4d267-38c3-48ad-a4c0-58e234d5d965" xlink:href="xfor-20221231.xsd#xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageContractualTermAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:to="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageContractualTermAbstract_41b4d267-38c3-48ad-a4c0-58e234d5d965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7eda0480-ef41-40b2-b91a-c40a00229bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageContractualTermAbstract_41b4d267-38c3-48ad-a4c0-58e234d5d965" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7eda0480-ef41-40b2-b91a-c40a00229bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_27a7b203-3bc6-41f8-bb15-30b4a2b5fdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageContractualTermAbstract_41b4d267-38c3-48ad-a4c0-58e234d5d965" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_27a7b203-3bc6-41f8-bb15-30b4a2b5fdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f8bd8c69-057d-41c2-9dca-2d5b831b955f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageContractualTermAbstract_41b4d267-38c3-48ad-a4c0-58e234d5d965" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f8bd8c69-057d-41c2-9dca-2d5b831b955f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract_764b2d67-8b03-42f0-bd6b-7070d112c8aa" xlink:href="xfor-20221231.xsd#xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2d32977-2283-497c-8dae-e1b1efb5ffa4" xlink:to="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract_764b2d67-8b03-42f0-bd6b-7070d112c8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_5223cd30-7c1d-4808-a44d-01c4d1799988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract_764b2d67-8b03-42f0-bd6b-7070d112c8aa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_5223cd30-7c1d-4808-a44d-01c4d1799988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_6c1ab4c7-0d77-48fb-8add-86f3128ce44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract_764b2d67-8b03-42f0-bd6b-7070d112c8aa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_6c1ab4c7-0d77-48fb-8add-86f3128ce44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_299ebb6e-b884-433a-9913-ebf812abb7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract_764b2d67-8b03-42f0-bd6b-7070d112c8aa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_299ebb6e-b884-433a-9913-ebf812abb7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4d341e88-30b4-45cc-9c01-3d3753be86c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract_764b2d67-8b03-42f0-bd6b-7070d112c8aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4d341e88-30b4-45cc-9c01-3d3753be86c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#StockBasedCompensationRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3fdfdcd5-3e0d-43f7-b085-3e9c772a28fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a028e5e0-0278-4bd2-b39b-5350243925cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3fdfdcd5-3e0d-43f7-b085-3e9c772a28fa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a028e5e0-0278-4bd2-b39b-5350243925cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a8df8e61-aa8c-494c-8332-a2bc78976d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a028e5e0-0278-4bd2-b39b-5350243925cc" xlink:to="loc_us-gaap_AwardTypeAxis_a8df8e61-aa8c-494c-8332-a2bc78976d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57b8500e-fde8-4f0a-9e71-3bede9148048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a8df8e61-aa8c-494c-8332-a2bc78976d2b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57b8500e-fde8-4f0a-9e71-3bede9148048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_079e4be6-d63d-45ca-aa2e-e5c52f47c861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57b8500e-fde8-4f0a-9e71-3bede9148048" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_079e4be6-d63d-45ca-aa2e-e5c52f47c861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b549b6ad-f1dc-4fd7-b802-4224104e7c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a028e5e0-0278-4bd2-b39b-5350243925cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b549b6ad-f1dc-4fd7-b802-4224104e7c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_67065534-7367-4655-90da-a8b40a73787a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b549b6ad-f1dc-4fd7-b802-4224104e7c08" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_67065534-7367-4655-90da-a8b40a73787a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3fb7525c-f0e6-41a6-8ab4-2acb9a67d96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_67065534-7367-4655-90da-a8b40a73787a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3fb7525c-f0e6-41a6-8ab4-2acb9a67d96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_18df5277-d55c-4f95-8820-0f6efb170481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_67065534-7367-4655-90da-a8b40a73787a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_18df5277-d55c-4f95-8820-0f6efb170481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_47a6b599-a78a-4dc7-9409-d70de77c6e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_67065534-7367-4655-90da-a8b40a73787a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_47a6b599-a78a-4dc7-9409-d70de77c6e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6908d95a-58e5-4eee-babc-e50c6402f9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_67065534-7367-4655-90da-a8b40a73787a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6908d95a-58e5-4eee-babc-e50c6402f9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a197c0cd-b657-443a-97f7-7e922932438c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_67065534-7367-4655-90da-a8b40a73787a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a197c0cd-b657-443a-97f7-7e922932438c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseClassificationDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseClassificationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseClassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_591b88fd-6731-485c-8ff0-07196375df31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ec3cec8-c5e1-47f8-987c-2ad14027d203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_591b88fd-6731-485c-8ff0-07196375df31" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ec3cec8-c5e1-47f8-987c-2ad14027d203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3d11342b-2eb1-4f87-b8bc-5324287ab2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ec3cec8-c5e1-47f8-987c-2ad14027d203" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3d11342b-2eb1-4f87-b8bc-5324287ab2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cacc011b-d0c6-46e7-a2f9-7f72b41c9a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3d11342b-2eb1-4f87-b8bc-5324287ab2b4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cacc011b-d0c6-46e7-a2f9-7f72b41c9a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4fcfbfe5-41dc-455f-924f-c73212d1f622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cacc011b-d0c6-46e7-a2f9-7f72b41c9a62" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4fcfbfe5-41dc-455f-924f-c73212d1f622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_702ffab3-2762-421c-9e84-000a84e315fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cacc011b-d0c6-46e7-a2f9-7f72b41c9a62" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_702ffab3-2762-421c-9e84-000a84e315fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a453d52b-df67-467b-9f18-c494e324b0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ec3cec8-c5e1-47f8-987c-2ad14027d203" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a453d52b-df67-467b-9f18-c494e324b0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_15343ba6-2bd0-4cff-9377-85f22aecca80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a453d52b-df67-467b-9f18-c494e324b0e8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_15343ba6-2bd0-4cff-9377-85f22aecca80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationStockOptionValuationDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#StockBasedCompensationStockOptionValuationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationStockOptionValuationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_392439d4-0fe9-4c98-888d-13df8cf9d474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b463efc1-153c-4af3-a2b2-a0d7f64ac2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_392439d4-0fe9-4c98-888d-13df8cf9d474" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b463efc1-153c-4af3-a2b2-a0d7f64ac2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1d3e4f35-e1a1-4f34-846b-77ac9c782171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b463efc1-153c-4af3-a2b2-a0d7f64ac2cc" xlink:to="loc_us-gaap_AwardTypeAxis_1d3e4f35-e1a1-4f34-846b-77ac9c782171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1d4f2d8a-15b9-48a6-9760-51610becfc22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1d3e4f35-e1a1-4f34-846b-77ac9c782171" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1d4f2d8a-15b9-48a6-9760-51610becfc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_a1733fc0-5541-4df4-a789-66cb566ed73e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1d4f2d8a-15b9-48a6-9760-51610becfc22" xlink:to="loc_us-gaap_WarrantMember_a1733fc0-5541-4df4-a789-66cb566ed73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39f8155f-dc1a-41af-aabd-785562ad93c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b463efc1-153c-4af3-a2b2-a0d7f64ac2cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39f8155f-dc1a-41af-aabd-785562ad93c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c3cd2243-6ca7-4601-92e3-2a29bda361fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39f8155f-dc1a-41af-aabd-785562ad93c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c3cd2243-6ca7-4601-92e3-2a29bda361fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3c4b536a-77af-4e86-8a4a-7d47e119161c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39f8155f-dc1a-41af-aabd-785562ad93c3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3c4b536a-77af-4e86-8a4a-7d47e119161c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_43e806bc-8e05-4414-86c3-947697ffc67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39f8155f-dc1a-41af-aabd-785562ad93c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_43e806bc-8e05-4414-86c3-947697ffc67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ba70db8a-198a-4ac2-a79c-3e057b5e4245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39f8155f-dc1a-41af-aabd-785562ad93c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ba70db8a-198a-4ac2-a79c-3e057b5e4245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate_f263d3d1-71f3-4ea6-8ed6-c7de86dc05b3" xlink:href="xfor-20221231.xsd#xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39f8155f-dc1a-41af-aabd-785562ad93c3" xlink:to="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate_f263d3d1-71f3-4ea6-8ed6-c7de86dc05b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxesScheduleofIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#IncomeTaxesScheduleofIncomeLossBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxesScheduleofIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_554f1214-2967-49c7-9c63-50bf46955660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_fbd40b25-4411-4cfb-aa77-807c8a7cab3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_554f1214-2967-49c7-9c63-50bf46955660" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_fbd40b25-4411-4cfb-aa77-807c8a7cab3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_88f962e0-69bc-43ea-839f-ce0d446a30e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_554f1214-2967-49c7-9c63-50bf46955660" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_88f962e0-69bc-43ea-839f-ce0d446a30e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a148be17-0f90-48b6-b1b5-5b64a977d77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_554f1214-2967-49c7-9c63-50bf46955660" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a148be17-0f90-48b6-b1b5-5b64a977d77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_247a8606-399e-4955-a061-ff43e6f4a2af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c8eb08b9-1fb8-40b5-be03-8e6c6d9f3d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_247a8606-399e-4955-a061-ff43e6f4a2af" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c8eb08b9-1fb8-40b5-be03-8e6c6d9f3d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a240f116-39a1-496e-a485-b4e04c4adafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_247a8606-399e-4955-a061-ff43e6f4a2af" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a240f116-39a1-496e-a485-b4e04c4adafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_48981d29-1737-456b-973b-bc8cc4bea7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_247a8606-399e-4955-a061-ff43e6f4a2af" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_48981d29-1737-456b-973b-bc8cc4bea7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences_709d5964-c67e-4608-85ab-30585c9b6492" xlink:href="xfor-20221231.xsd#xfor_EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_247a8606-399e-4955-a061-ff43e6f4a2af" xlink:to="loc_xfor_EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences_709d5964-c67e-4608-85ab-30585c9b6492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_524ad378-d799-4e05-9844-c4ebfbb6cc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_247a8606-399e-4955-a061-ff43e6f4a2af" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_524ad378-d799-4e05-9844-c4ebfbb6cc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1ff2e81f-00d5-40e6-8a7c-134d4797d7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_247a8606-399e-4955-a061-ff43e6f4a2af" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1ff2e81f-00d5-40e6-8a7c-134d4797d7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_97428f2e-8fe5-437f-a43e-d0070489c4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_247a8606-399e-4955-a061-ff43e6f4a2af" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_97428f2e-8fe5-437f-a43e-d0070489c4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxesDeferredIncomeTaxAssetDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#IncomeTaxesDeferredIncomeTaxAssetDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxesDeferredIncomeTaxAssetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_14d0f5f6-86a4-4ba8-b79d-9c8eea02e576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_728151bb-496e-4b45-bac2-d651473291c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_14d0f5f6-86a4-4ba8-b79d-9c8eea02e576" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_728151bb-496e-4b45-bac2-d651473291c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_728151bb-496e-4b45-bac2-d651473291c5" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b3d2350d-237c-4300-a71b-5e25fd71d30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b3d2350d-237c-4300-a71b-5e25fd71d30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_fbcf13ca-a2d0-46fc-bbc2-99240325244c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_fbcf13ca-a2d0-46fc-bbc2-99240325244c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DeferredTaxAssetsTaxDeferredExpenseCapitalizedResearchAndDevelopmentCosts_f01e77c3-ebd6-4c2f-b842-68313f62e160" xlink:href="xfor-20221231.xsd#xfor_DeferredTaxAssetsTaxDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_xfor_DeferredTaxAssetsTaxDeferredExpenseCapitalizedResearchAndDevelopmentCosts_f01e77c3-ebd6-4c2f-b842-68313f62e160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DeferredTaxAssetLeaseLiability_2ca6c90a-88cc-4336-895f-2edea54f4f3e" xlink:href="xfor-20221231.xsd#xfor_DeferredTaxAssetLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_xfor_DeferredTaxAssetLeaseLiability_2ca6c90a-88cc-4336-895f-2edea54f4f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_eea567ba-0107-42f1-8cac-088649bc44b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_eea567ba-0107-42f1-8cac-088649bc44b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_cb38350b-2c0f-4924-8d5c-9daa57a01e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_cb38350b-2c0f-4924-8d5c-9daa57a01e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2faa36ad-2bde-4dd5-9ef5-d841fcbf0020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2faa36ad-2bde-4dd5-9ef5-d841fcbf0020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_93f263a0-a5cf-43cd-80b5-9c74201d14af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_93f263a0-a5cf-43cd-80b5-9c74201d14af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DeferredTaxLiabilityRightOfUseAsset_a8714f98-7451-4b20-b30a-1c44430bb54e" xlink:href="xfor-20221231.xsd#xfor_DeferredTaxLiabilityRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_xfor_DeferredTaxLiabilityRightOfUseAsset_a8714f98-7451-4b20-b30a-1c44430bb54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_9ddc6a6c-b7ea-4020-a7ac-1f43395a3c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_9ddc6a6c-b7ea-4020-a7ac-1f43395a3c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dcfefd07-4dc8-4a92-9b6f-dbdd4b2a2881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e392432d-98e1-4fcd-81f2-4a225c272f0e" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dcfefd07-4dc8-4a92-9b6f-dbdd4b2a2881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4a433b7f-a780-4d3b-8f9f-a88fecc4657a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_f108e7a1-cf64-47c9-9ee7-de5a20694614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4a433b7f-a780-4d3b-8f9f-a88fecc4657a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_f108e7a1-cf64-47c9-9ee7-de5a20694614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_e713cbba-28be-4377-9bb4-e0fa885d5aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f108e7a1-cf64-47c9-9ee7-de5a20694614" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_e713cbba-28be-4377-9bb4-e0fa885d5aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_fbcdcf4b-130a-4abf-be24-d46360378fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_e713cbba-28be-4377-9bb4-e0fa885d5aab" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_fbcdcf4b-130a-4abf-be24-d46360378fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_d4f7dbe6-afdc-460e-9b0c-7d7d846fc5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_fbcdcf4b-130a-4abf-be24-d46360378fc7" xlink:to="loc_us-gaap_ResearchMember_d4f7dbe6-afdc-460e-9b0c-7d7d846fc5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c0562330-cdab-422c-9b81-8ed53622f99e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f108e7a1-cf64-47c9-9ee7-de5a20694614" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c0562330-cdab-422c-9b81-8ed53622f99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8f355a55-bd81-4637-8a79-2bfa0bb7bf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c0562330-cdab-422c-9b81-8ed53622f99e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8f355a55-bd81-4637-8a79-2bfa0bb7bf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e39fb2d3-9559-4631-8731-1d41ee07101a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8f355a55-bd81-4637-8a79-2bfa0bb7bf56" xlink:to="loc_us-gaap_DomesticCountryMember_e39fb2d3-9559-4631-8731-1d41ee07101a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_dc5058ad-b932-435d-a100-476c724d0c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8f355a55-bd81-4637-8a79-2bfa0bb7bf56" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_dc5058ad-b932-435d-a100-476c724d0c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_ae176754-494a-4587-a858-3f755956d04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8f355a55-bd81-4637-8a79-2bfa0bb7bf56" xlink:to="loc_us-gaap_ForeignCountryMember_ae176754-494a-4587-a858-3f755956d04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f108e7a1-cf64-47c9-9ee7-de5a20694614" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_0b636d71-305b-480e-b7a2-fac918aac082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:to="loc_us-gaap_OperatingLossCarryforwards_0b636d71-305b-480e-b7a2-fac918aac082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_267a0769-5a62-432b-a7de-fc3c66ffbe3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_267a0769-5a62-432b-a7de-fc3c66ffbe3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_955bca2f-c763-4e32-8559-6af048de4c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_955bca2f-c763-4e32-8559-6af048de4c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_f368e8b3-8e24-4951-b643-6d6a103cbc78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_f368e8b3-8e24-4951-b643-6d6a103cbc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TaxCutsAndJobsActCapitalizedCosts_98aafb68-5ddd-408a-a45a-cbaa36df3944" xlink:href="xfor-20221231.xsd#xfor_TaxCutsAndJobsActCapitalizedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:to="loc_xfor_TaxCutsAndJobsActCapitalizedCosts_98aafb68-5ddd-408a-a45a-cbaa36df3944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TaxCutsAndJobsActCostsAmortized_f1d27ac8-9694-4566-8276-bdf9b3eccd82" xlink:href="xfor-20221231.xsd#xfor_TaxCutsAndJobsActCostsAmortized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:to="loc_xfor_TaxCutsAndJobsActCostsAmortized_f1d27ac8-9694-4566-8276-bdf9b3eccd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TaxCutsAndJobsActDeferredTaxAssets_ce2989e4-2b00-403a-b1a9-ca2982872ee1" xlink:href="xfor-20221231.xsd#xfor_TaxCutsAndJobsActDeferredTaxAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:to="loc_xfor_TaxCutsAndJobsActDeferredTaxAssets_ce2989e4-2b00-403a-b1a9-ca2982872ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e27f894d-1d2f-4c7f-9a82-7bdc74ecfab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8a82e61d-b385-457b-99e0-1fac3c644c71" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e27f894d-1d2f-4c7f-9a82-7bdc74ecfab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxesDeferredTaxValuationAllowanceDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#IncomeTaxesDeferredTaxValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxesDeferredTaxValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8c23f253-e03f-47cf-8c6a-e304cc4f8f26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_46c75b4a-5ad7-4fa6-a690-f81a9ddfab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8c23f253-e03f-47cf-8c6a-e304cc4f8f26" xlink:to="loc_us-gaap_ValuationAllowanceTable_46c75b4a-5ad7-4fa6-a690-f81a9ddfab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_f4b2b21b-f6ed-4d19-acd7-5df39cc59182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_46c75b4a-5ad7-4fa6-a690-f81a9ddfab8b" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_f4b2b21b-f6ed-4d19-acd7-5df39cc59182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_c65f65a4-8fa8-4070-8a03-a182b63d1a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_f4b2b21b-f6ed-4d19-acd7-5df39cc59182" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_c65f65a4-8fa8-4070-8a03-a182b63d1a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_649805cc-0a90-4610-bbbf-eccfc172af42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_c65f65a4-8fa8-4070-8a03-a182b63d1a9c" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_649805cc-0a90-4610-bbbf-eccfc172af42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_b109e046-2ccb-4f88-a356-8ac25b16c361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_46c75b4a-5ad7-4fa6-a690-f81a9ddfab8b" xlink:to="loc_us-gaap_ValuationAllowanceLineItems_b109e046-2ccb-4f88-a356-8ac25b16c361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_fb0a7ab1-488b-4189-85ad-05d617391108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_b109e046-2ccb-4f88-a356-8ac25b16c361" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_fb0a7ab1-488b-4189-85ad-05d617391108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_95435a22-f19c-47ef-a6ca-2594135ee8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_fb0a7ab1-488b-4189-85ad-05d617391108" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_95435a22-f19c-47ef-a6ca-2594135ee8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_d4b89e61-2cae-482b-ada7-9cc70255721b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_fb0a7ab1-488b-4189-85ad-05d617391108" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_d4b89e61-2cae-482b-ada7-9cc70255721b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_9bc0a38f-7a83-4521-a3d6-e6ae739de888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_fb0a7ab1-488b-4189-85ad-05d617391108" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_9bc0a38f-7a83-4521-a3d6-e6ae739de888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_013efc22-d0d5-42b5-8968-28367d18b320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_fd391a46-0775-4563-8505-c525e2305193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_013efc22-d0d5-42b5-8968-28367d18b320" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_fd391a46-0775-4563-8505-c525e2305193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_9d4ff6f3-97d1-41d3-b15f-95d600489d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_013efc22-d0d5-42b5-8968-28367d18b320" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_9d4ff6f3-97d1-41d3-b15f-95d600489d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShareSummaryofBasicandDilutedNetlossperShareAttributabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#NetLossperShareSummaryofBasicandDilutedNetlossperShareAttributabletoCommonStockholdersDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShareSummaryofBasicandDilutedNetlossperShareAttributabletoCommonStockholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_35c24943-a325-4422-964d-9f70bff34757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0af99eb8-7113-4c26-8785-c5c3ef59f150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35c24943-a325-4422-964d-9f70bff34757" xlink:to="loc_us-gaap_NetIncomeLoss_0af99eb8-7113-4c26-8785-c5c3ef59f150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock_2aa26960-8fdf-4ff6-909b-213a36bc7614" xlink:href="xfor-20221231.xsd#xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35c24943-a325-4422-964d-9f70bff34757" xlink:to="loc_xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock_2aa26960-8fdf-4ff6-909b-213a36bc7614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_721510de-f526-40be-a185-36f6ec71fec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35c24943-a325-4422-964d-9f70bff34757" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_721510de-f526-40be-a185-36f6ec71fec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_61bd44dd-33b5-43df-94a5-fe86d61c0895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35c24943-a325-4422-964d-9f70bff34757" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_61bd44dd-33b5-43df-94a5-fe86d61c0895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1d108e2-fa58-4ac8-9dd8-ea4770ef620b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35c24943-a325-4422-964d-9f70bff34757" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1d108e2-fa58-4ac8-9dd8-ea4770ef620b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_93e5caeb-3b96-4573-bf74-6867b8883316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35c24943-a325-4422-964d-9f70bff34757" xlink:to="loc_us-gaap_EarningsPerShareBasic_93e5caeb-3b96-4573-bf74-6867b8883316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3ab1f70a-6326-45d2-9799-41e7f8b85c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35c24943-a325-4422-964d-9f70bff34757" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3ab1f70a-6326-45d2-9799-41e7f8b85c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShareAdditionalInformationDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#NetLossperShareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_38d2fd9e-27ba-43b8-bb8d-14538b4164f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_5dfa93d8-cca8-4256-b3c1-2bc73a7cb6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38d2fd9e-27ba-43b8-bb8d-14538b4164f8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_5dfa93d8-cca8-4256-b3c1-2bc73a7cb6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_68ad7697-3e43-4b74-9694-294f0c97498e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_5dfa93d8-cca8-4256-b3c1-2bc73a7cb6fd" xlink:to="loc_us-gaap_StatementClassOfStockAxis_68ad7697-3e43-4b74-9694-294f0c97498e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_89e6dd98-9158-48b0-a505-029a92a12b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_68ad7697-3e43-4b74-9694-294f0c97498e" xlink:to="loc_us-gaap_ClassOfStockDomain_89e6dd98-9158-48b0-a505-029a92a12b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_RedeemableCommonStockMember_4044322d-c74e-4194-9916-fa6f17054bbb" xlink:href="xfor-20221231.xsd#xfor_RedeemableCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_89e6dd98-9158-48b0-a505-029a92a12b46" xlink:to="loc_xfor_RedeemableCommonStockMember_4044322d-c74e-4194-9916-fa6f17054bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e70b096c-dc28-4a82-aa3f-989e462dbe6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_5dfa93d8-cca8-4256-b3c1-2bc73a7cb6fd" xlink:to="loc_srt_RangeAxis_e70b096c-dc28-4a82-aa3f-989e462dbe6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1e14ed5b-a821-4518-8352-c4a074118846" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e70b096c-dc28-4a82-aa3f-989e462dbe6b" xlink:to="loc_srt_RangeMember_1e14ed5b-a821-4518-8352-c4a074118846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_69a3572d-eafc-4ab5-95b0-fb0021e0f1ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1e14ed5b-a821-4518-8352-c4a074118846" xlink:to="loc_srt_MinimumMember_69a3572d-eafc-4ab5-95b0-fb0021e0f1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b46271f3-88e5-4eca-827c-4037b628e04b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_5dfa93d8-cca8-4256-b3c1-2bc73a7cb6fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b46271f3-88e5-4eca-827c-4037b628e04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_35661ad1-b372-41a8-b9b0-d04969c23057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b46271f3-88e5-4eca-827c-4037b628e04b" xlink:to="loc_us-gaap_EquityComponentDomain_35661ad1-b372-41a8-b9b0-d04969c23057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_352e5f5b-493a-43b2-82e2-e8632f328e31" xlink:href="xfor-20221231.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_35661ad1-b372-41a8-b9b0-d04969c23057" xlink:to="loc_xfor_PreFundedWarrantMember_352e5f5b-493a-43b2-82e2-e8632f328e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_78d1222b-fa7d-4529-a07c-c715ba2572f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_5dfa93d8-cca8-4256-b3c1-2bc73a7cb6fd" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_78d1222b-fa7d-4529-a07c-c715ba2572f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1fe3ca1e-c574-4d98-bd55-05b718ee0ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_78d1222b-fa7d-4529-a07c-c715ba2572f3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1fe3ca1e-c574-4d98-bd55-05b718ee0ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7047e491-b15c-44da-96ed-12383e44608d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_78d1222b-fa7d-4529-a07c-c715ba2572f3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7047e491-b15c-44da-96ed-12383e44608d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_40ac7bb7-bbe6-4068-a6e9-fcc0dde62715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_78d1222b-fa7d-4529-a07c-c715ba2572f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_40ac7bb7-bbe6-4068-a6e9-fcc0dde62715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedNetLossperShareAttributabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#NetLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedNetLossperShareAttributabletoCommonStockholdersDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedNetLossperShareAttributabletoCommonStockholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0bacaa6f-fea2-4f7d-8ea1-904c3fc1b48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_039d65ef-c027-4098-9c19-e24b89bfd178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0bacaa6f-fea2-4f7d-8ea1-904c3fc1b48f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_039d65ef-c027-4098-9c19-e24b89bfd178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d46140fc-8246-49de-bdaa-34361f2fab5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_039d65ef-c027-4098-9c19-e24b89bfd178" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d46140fc-8246-49de-bdaa-34361f2fab5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ebd6201-cd4e-496d-a8c9-7116f10e3dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d46140fc-8246-49de-bdaa-34361f2fab5c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ebd6201-cd4e-496d-a8c9-7116f10e3dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_22689250-209c-4a45-bd19-3bb63cb3eea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ebd6201-cd4e-496d-a8c9-7116f10e3dfd" xlink:to="loc_us-gaap_WarrantMember_22689250-209c-4a45-bd19-3bb63cb3eea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_973756e9-bf3e-419c-b101-8022807a2c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ebd6201-cd4e-496d-a8c9-7116f10e3dfd" xlink:to="loc_us-gaap_StockOptionMember_973756e9-bf3e-419c-b101-8022807a2c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1aaf8d30-fed3-4a89-b0c3-860ee6e2576c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ebd6201-cd4e-496d-a8c9-7116f10e3dfd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1aaf8d30-fed3-4a89-b0c3-860ee6e2576c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_106c6e89-711c-4acc-9735-19c93b1fadf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_039d65ef-c027-4098-9c19-e24b89bfd178" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_106c6e89-711c-4acc-9735-19c93b1fadf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fa76c8e4-1265-4d20-b80e-68a89beeb4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_106c6e89-711c-4acc-9735-19c93b1fadf9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fa76c8e4-1265-4d20-b80e-68a89beeb4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="xfor-20221231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_95995db6-31bd-4c39-b858-06bc1f83cd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a3098025-8e3e-4fa3-9d63-bcb6318b9f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_95995db6-31bd-4c39-b858-06bc1f83cd1c" xlink:to="loc_us-gaap_SubsequentEventTable_a3098025-8e3e-4fa3-9d63-bcb6318b9f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e3a79d8c-9148-4e39-88b7-429c3cdcc781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a3098025-8e3e-4fa3-9d63-bcb6318b9f3d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e3a79d8c-9148-4e39-88b7-429c3cdcc781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bb62a15a-6dfd-4f80-9f84-1ed53ca65720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e3a79d8c-9148-4e39-88b7-429c3cdcc781" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bb62a15a-6dfd-4f80-9f84-1ed53ca65720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d3485cc1-4134-4bd7-845f-26f13bb4961b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bb62a15a-6dfd-4f80-9f84-1ed53ca65720" xlink:to="loc_us-gaap_SubsequentEventMember_d3485cc1-4134-4bd7-845f-26f13bb4961b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c74a1fff-b666-4d2e-bc6c-edafaf805ca7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a3098025-8e3e-4fa3-9d63-bcb6318b9f3d" xlink:to="loc_srt_RangeAxis_c74a1fff-b666-4d2e-bc6c-edafaf805ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0f81c0a-7df4-4f33-8a70-27a9f464ac5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c74a1fff-b666-4d2e-bc6c-edafaf805ca7" xlink:to="loc_srt_RangeMember_b0f81c0a-7df4-4f33-8a70-27a9f464ac5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_84a3b79e-1333-4ec4-b6df-3b629b3ec7cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0f81c0a-7df4-4f33-8a70-27a9f464ac5b" xlink:to="loc_srt_MinimumMember_84a3b79e-1333-4ec4-b6df-3b629b3ec7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_509a65e4-34a7-46d9-b54c-55081aae3647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a3098025-8e3e-4fa3-9d63-bcb6318b9f3d" xlink:to="loc_us-gaap_DebtInstrumentAxis_509a65e4-34a7-46d9-b54c-55081aae3647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc2e1fa1-4743-4300-b1ca-d4230de2c853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_509a65e4-34a7-46d9-b54c-55081aae3647" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc2e1fa1-4743-4300-b1ca-d4230de2c853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SecondARLoanAgreementMember_dd6a2d60-a510-441e-82b4-c4ba54d09866" xlink:href="xfor-20221231.xsd#xfor_SecondARLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc2e1fa1-4743-4300-b1ca-d4230de2c853" xlink:to="loc_xfor_SecondARLoanAgreementMember_dd6a2d60-a510-441e-82b4-c4ba54d09866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesAmendedAndRestatedLoanAgreementMember_7c6f79a7-ac29-4e3d-86b9-138e2674db52" xlink:href="xfor-20221231.xsd#xfor_HerculesAmendedAndRestatedLoanAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc2e1fa1-4743-4300-b1ca-d4230de2c853" xlink:to="loc_xfor_HerculesAmendedAndRestatedLoanAgreementMember_7c6f79a7-ac29-4e3d-86b9-138e2674db52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_137adb4f-eeeb-4f6b-81e2-41a411de24c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a3098025-8e3e-4fa3-9d63-bcb6318b9f3d" xlink:to="loc_us-gaap_SubsequentEventLineItems_137adb4f-eeeb-4f6b-81e2-41a411de24c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_239a38da-43c0-4971-9567-797a30bf2e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_137adb4f-eeeb-4f6b-81e2-41a411de24c6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_239a38da-43c0-4971-9567-797a30bf2e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_452cd3e3-689e-4f01-ae57-f30b20d296b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_137adb4f-eeeb-4f6b-81e2-41a411de24c6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_452cd3e3-689e-4f01-ae57-f30b20d296b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a19fa7e9-a3ff-4d25-881c-0aad78abdea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_137adb4f-eeeb-4f6b-81e2-41a411de24c6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a19fa7e9-a3ff-4d25-881c-0aad78abdea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_7d720fb0-0025-4193-808e-341fb0979f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_137adb4f-eeeb-4f6b-81e2-41a411de24c6" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_7d720fb0-0025-4193-808e-341fb0979f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequired_248063cd-e52a-424c-91bb-58a191e934f8" xlink:href="xfor-20221231.xsd#xfor_DebtInstrumentDebtCovenantMinimumCashRequired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_137adb4f-eeeb-4f6b-81e2-41a411de24c6" xlink:to="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequired_248063cd-e52a-424c-91bb-58a191e934f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequiredConditionalScenario_19678765-0d26-4c64-b2cd-7df53687cd85" xlink:href="xfor-20221231.xsd#xfor_DebtInstrumentDebtCovenantMinimumCashRequiredConditionalScenario"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_137adb4f-eeeb-4f6b-81e2-41a411de24c6" xlink:to="loc_xfor_DebtInstrumentDebtCovenantMinimumCashRequiredConditionalScenario_19678765-0d26-4c64-b2cd-7df53687cd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
